<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Brain</journal-id>
      <journal-id journal-id-type="iso-abbrev">Brain</journal-id>
      <journal-id journal-id-type="publisher-id">brainj</journal-id>
      <journal-title-group>
        <journal-title>Brain</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-8950</issn>
      <issn pub-type="epub">1460-2156</issn>
      <publisher>
        <publisher-name>Oxford University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35718349</article-id>
      <article-id pub-id-type="pmc">9473353</article-id>
      <article-id pub-id-type="doi">10.1093/brain/awac123</article-id>
      <article-id pub-id-type="publisher-id">awac123</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="category-taxonomy-collection">
          <subject>AcademicSubjects/MED00310</subject>
          <subject>AcademicSubjects/SCI01870</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>TMEM63C mutations cause mitochondrial morphology defects and underlie
hereditary spastic paraplegia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7684-3811</contrib-id>
          <name>
            <surname>T&#xE1;bara</surname>
            <given-names>Luis Carlos</given-names>
          </name>
          <aff>
<institution>Medical Research Council Mitochondrial Biology Unit, University of
Cambridge</institution>, <addr-line>Cambridge CB2 0XY</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="awac123-FM1" ref-type="author-notes"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Salmi</surname>
            <given-names>Fatema</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="awac123-FM1" ref-type="author-notes"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maroofian</surname>
            <given-names>Reza</given-names>
          </name>
          <aff>
<institution>UCL Queen Square Institute of Neurology, University College
London</institution>, <addr-line>London WC1E 6BT</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="awac123-FM1" ref-type="author-notes"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Futaisi</surname>
            <given-names>Amna Mohammed</given-names>
          </name>
          <aff>
<institution>Genetic and Developmental Medicine Clinic, Department of Genetics, College
of Medicine and Health Sciences, Sultan Qaboos University Hospital</institution>,
<addr-line>Muscat 123</addr-line>, <country country="OM">Oman</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Murshedi</surname>
            <given-names>Fathiya</given-names>
          </name>
          <aff>
<institution>Genetic and Developmental Medicine Clinic, Department of Genetics, College
of Medicine and Health Sciences, Sultan Qaboos University Hospital</institution>,
<addr-line>Muscat 123</addr-line>, <country country="OM">Oman</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kennedy</surname>
            <given-names>Joanna</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>Clinical Genetics, University Hospitals Bristol</institution>,
<addr-line>Bristol BS2 8EG</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Day</surname>
            <given-names>Jacob O</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>Faculty of Health, University of Plymouth</institution>,
<addr-line>Plymouth PL4 8AA</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0275-2498</contrib-id>
          <name>
            <surname>Courtin</surname>
            <given-names>Thomas</given-names>
          </name>
          <aff>
<institution>D&#xE9;partement de g&#xE9;n&#xE9;tique, H&#xF4;pital Piti&#xE9;-Salp&#xEA;tri&#xE8;re, Assistance
Publique-H&#xF4;pitaux de Paris</institution>, <addr-line>75019 Paris, Sorbonne
Universit&#xE9;</addr-line>, <country country="FR">France</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Khayat</surname>
            <given-names>Aisha</given-names>
          </name>
          <aff>
<institution>Department of Biology, College of Science, Sultan Qaboos
University</institution>, <addr-line>Muscat</addr-line>, <country country="OM">Oman</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Galedari</surname>
            <given-names>Hamid</given-names>
          </name>
          <aff>
<institution>Department of Genetics, Faculty of Science, Shahid Chamran University of
Ahvaz</institution>, <addr-line>Ahvaz</addr-line>, <country country="IR">Iran</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mazaheri</surname>
            <given-names>Neda</given-names>
          </name>
          <aff>
<institution>Department of Genetics, Faculty of Science, Shahid Chamran University of
Ahvaz</institution>, <addr-line>Ahvaz</addr-line>, <country country="IR">Iran</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Protasoni</surname>
            <given-names>Margherita</given-names>
          </name>
          <aff>
<institution>Medical Research Council Mitochondrial Biology Unit, University of
Cambridge</institution>, <addr-line>Cambridge CB2 0XY</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Johnson</surname>
            <given-names>Mark</given-names>
          </name>
          <aff>
<institution>Medical Research Council Mitochondrial Biology Unit, University of
Cambridge</institution>, <addr-line>Cambridge CB2 0XY</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0972-8818</contrib-id>
          <name>
            <surname>Leslie</surname>
            <given-names>Joseph S</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salter</surname>
            <given-names>Claire G</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6764-253X</contrib-id>
          <name>
            <surname>Rawlins</surname>
            <given-names>Lettie E</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>Peninsula Clinical Genetics Service, Royal Devon and Exeter Hospital
(Heavitree)</institution>, <addr-line>Exeter EX1 2ED</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fasham</surname>
            <given-names>James</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>Peninsula Clinical Genetics Service, Royal Devon and Exeter Hospital
(Heavitree)</institution>, <addr-line>Exeter EX1 2ED</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Maawali</surname>
            <given-names>Almundher</given-names>
          </name>
          <aff>
<institution>Genetic and Developmental Medicine Clinic, Department of Genetics, College
of Medicine and Health Sciences, Sultan Qaboos University Hospital</institution>,
<addr-line>Muscat 123</addr-line>, <country country="OM">Oman</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Voutsina</surname>
            <given-names>Nikol</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Charles</surname>
            <given-names>Perrine</given-names>
          </name>
          <aff>
<institution>D&#xE9;partement de g&#xE9;n&#xE9;tique, H&#xF4;pital Piti&#xE9;-Salp&#xEA;tri&#xE8;re, Assistance
Publique-H&#xF4;pitaux de Paris</institution>, <addr-line>75019 Paris, Sorbonne
Universit&#xE9;</addr-line>, <country country="FR">France</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harrold</surname>
            <given-names>Laura</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Keren</surname>
            <given-names>Boris</given-names>
          </name>
          <aff>
<institution>D&#xE9;partement de g&#xE9;n&#xE9;tique, H&#xF4;pital Piti&#xE9;-Salp&#xEA;tri&#xE8;re, Assistance
Publique-H&#xF4;pitaux de Paris</institution>, <addr-line>75019 Paris, Sorbonne
Universit&#xE9;</addr-line>, <country country="FR">France</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0610-4500</contrib-id>
          <name>
            <surname>Kunji</surname>
            <given-names>Edmund R S</given-names>
          </name>
          <aff>
<institution>Medical Research Council Mitochondrial Biology Unit, University of
Cambridge</institution>, <addr-line>Cambridge CB2 0XY</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6719-3447</contrib-id>
          <name>
            <surname>Vona</surname>
            <given-names>Barbara</given-names>
          </name>
          <aff>
<institution>Department of Otolaryngology-Head and Neck Surgery, T&#xFC;bingen Hearing
Research Centre, Eberhard Karls University T&#xFC;bingen</institution>,
<addr-line>T&#xFC;bingen</addr-line>, <country country="DE">Germany</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jelodar</surname>
            <given-names>Gholamreza</given-names>
          </name>
          <aff>
<institution>Pediatric Neurology, Ahvaz Jundishapur University of Medical
Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country country="IR">Iran</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sedaghat</surname>
            <given-names>Alireza</given-names>
          </name>
          <aff>
<institution>Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur
University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country country="IR">Iran</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shariati</surname>
            <given-names>Gholamreza</given-names>
          </name>
          <aff>
<institution>Department of Medical Genetic, Faculty of Medicine, Ahvaz Jundishapur,
University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country country="IR">Iran</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2866-7777</contrib-id>
          <name>
            <surname>Houlden</surname>
            <given-names>Henry</given-names>
          </name>
          <aff>
<institution>UCL Queen Square Institute of Neurology, University College
London</institution>, <addr-line>London WC1E 6BT</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6637-3411</contrib-id>
          <name>
            <surname>Crosby</surname>
            <given-names>Andrew H</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="awac123-cor1" ref-type="corresp"/>
          <!--a.h.crosby@exeter.ac.uk-->
          <xref rid="awac123-FM1" ref-type="author-notes"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3821-6088</contrib-id>
          <name>
            <surname>Prudent</surname>
            <given-names>Julien</given-names>
          </name>
          <aff>
<institution>Medical Research Council Mitochondrial Biology Unit, University of
Cambridge</institution>, <addr-line>Cambridge CB2 0XY</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="awac123-cor2" ref-type="corresp"/>
          <xref rid="awac123-FM1" ref-type="author-notes"/>
          <!--julien.prudent@mrc-mbu.cam.ac.uk-->
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Baple</surname>
            <given-names>Emma L</given-names>
          </name>
          <aff>
<institution>Level 4, RILD Wellcome Wolfson Medical Research Centre, RD&amp;E (Wonford)
NHS Foundation Trust, University of Exeter Medical School</institution>,
<addr-line>Exeter EX2 5DW</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>Peninsula Clinical Genetics Service, Royal Devon and Exeter Hospital
(Heavitree)</institution>, <addr-line>Exeter EX1 2ED</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="awac123-cor3" ref-type="corresp"/>
          <!--e.baple@exeter.ac.uk-->
          <xref rid="awac123-FM1" ref-type="author-notes"/>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="awac123-cor1">Correspondence to: Professor Andrew Crosby RILD Wellcome Wolfson
Centre Royal Devon and Exeter NHS Foundation Trust Barrack Road, Exeter EX2 5DW, UK
E-mail: <email>a.h.crosby@exeter.ac.uk</email></corresp>
        <corresp id="awac123-cor2">Correspondence may also be addressed to: Dr Julien Prudent MRC
Mitochondrial Biology Unit University of Cambridge, The Keith Peters building Cambridge
Biomedical Campus Hills Road, Cambridge CB2 0XY, UK E-mail:
<email>julien.prudent@mrc-mbu.cam.ac.uk</email></corresp>
        <corresp id="awac123-cor3">Dr Emma Baple RILD Wellcome Wolfson Centre Royal Devon and Exeter
NHS Foundation Trust Barrack Road, Exeter, EX2 5DW, UK E-mail:
<email>e.baple@exeter.ac.uk</email></corresp>
        <fn id="awac123-FM1">
          <p>Luis Carlos T&#xE1;bara, Fatema Al-Salmi, Reza Maroofian, Andrew H Crosby, Julien Prudent
and Emma L Baple contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <month>9</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub" iso-8601-date="2022-06-18">
        <day>18</day>
        <month>6</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>6</month>
        <year>2022</year>
      </pub-date>
      <volume>145</volume>
      <issue>9</issue>
      <fpage>3095</fpage>
      <lpage>3107</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>7</month>
          <year>2021</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>2</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>3</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022. Published by Oxford University Press on behalf of
the Guarantors of Brain.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
reuse, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="awac123.pdf"/>
      <related-article related-article-type="correction-forward" ext-link-type="doi" id="RA1" xlink:href="10.1093/brain/awac254"/>
      <abstract>
        <title>Abstract</title>
        <p>The hereditary spastic paraplegias (HSP) are among the most genetically diverse of all
Mendelian disorders. They comprise a large group of neurodegenerative diseases that may be
divided into &#x2018;pure HSP&#x2019; in forms of the disease primarily entailing progressive lower-limb
weakness and spasticity, and &#x2018;complex HSP&#x2019; when these features are accompanied by other
neurological (or non-neurological) clinical signs. Here, we identified biallelic variants
in the transmembrane protein 63C (<italic toggle="yes">TMEM63C</italic>) gene, encoding a predicted
osmosensitive calcium-permeable cation channel, in individuals with hereditary spastic
paraplegias associated with mild intellectual disability in some, but not all cases.
Biochemical and microscopy analyses revealed that TMEM63C is an endoplasmic
reticulum-localized protein, which is particularly enriched at mitochondria&#x2013;endoplasmic
reticulum contact sites. Functional <italic toggle="yes">in cellula</italic> studies indicate a role
for TMEM63C in regulating both endoplasmic reticulum and mitochondrial morphologies.
Together, these findings identify autosomal recessive <italic toggle="yes">TMEM63C</italic> variants as
a cause of pure and complex HSP and add to the growing evidence of a fundamental
pathomolecular role of perturbed mitochondrial-endoplasmic reticulum dynamics in motor
neurone degenerative diseases.</p>
      </abstract>
      <abstract abstract-type="teaser">
        <p>Al-Salmi <italic toggle="yes">et al.</italic> show that <italic toggle="yes">TMEM63C</italic> variants cause HSP
with/without intellectual disability. Consistent with lipidomic imbalance being a common
feature of HSP, they show <italic toggle="yes">in cellulo</italic> that TMEM63C is enriched at
mitochondrial-ER contact sites and that <italic toggle="yes">TMEM63C</italic> knockout causes
mitochondrial morphology defects.</p>
      </abstract>
      <kwd-group>
        <kwd>TMEM63C</kwd>
        <kwd>hereditary spastic paraplegia/HSP</kwd>
        <kwd>mitochondria</kwd>
        <kwd>endoplasmic reticulum/ER</kwd>
        <kwd>mitochondria-ER contact sites/MERCs</kwd>
      </kwd-group>
      <funding-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Halpin Trust</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Hereditary Spastic Paraplegia Support Group</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Medical Research Council UK</institution></institution-wrap>
</funding-source>
          <award-id>MC_UU_00015/7</award-id>
          <award-id>G1002279</award-id>
          <award-id>G1001931</award-id>
          <award-id>MC-PC-18047</award-id>
          <award-id>MC_PC_15054</award-id>
          <award-id>MC_PC_15047</award-id>
        </award-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>University of Exeter</institution><institution-id institution-id-type="doi">10.13039/501100000737</institution-id></institution-wrap>
</funding-source>
        </award-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Newlife Foundation for Disabled Children</institution><institution-id institution-id-type="doi">10.13039/100016187</institution-id></institution-wrap>
</funding-source>
        </award-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Oman Ministry of Higher Education</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Sultanate of Oman</institution></institution-wrap>
</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="13"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="awac123-s1">
      <title>Introduction</title>
      <p>Hereditary spastic paraplegia (HSP) was first described by Strumpell and Lorrain in the
late 19th century and was initially considered to be a small group of Mendelian disorders.
However, subsequent advancements in our understanding of the genetic architecture of HSP
have led to it being recognized as one of the most genetically (&gt;80 causative genes) and
clinically heterogeneous of inherited diseases. HSP is characterized clinically by
lower-limb spasticity and weakness, and pathologically by the retrograde degeneration of
motor neurons.<sup><xref rid="awac123-B1" ref-type="bibr">1</xref>,<xref rid="awac123-B2" ref-type="bibr">2</xref></sup> HSP may be subdivided into pure and complex forms,
depending on whether other system involvement or neurological features accompany the
cardinal clinical sign of progressive lower-limb spastic weakness. Autosomal recessive forms
account for an estimated 25&#x2013;30% of HSP patients, typically involving complex forms of HSP
with additional clinical features including impaired vision and hearing, cognitive
impairment, seizures and peripheral neuropathy.<sup><xref rid="awac123-B1" ref-type="bibr">1</xref></sup> At present, there is no cure for the condition and treatments are
largely symptomatic, involving the use of antispasmodic agents such as baclofen, progabide
and dalfampridine.<sup><xref rid="awac123-B3" ref-type="bibr">3</xref></sup> Increasing
understanding of the biological basis of HSP is supporting the development of new
treatments, which have the potential to be personalized depending on the underlying genetic
cause.<sup><xref rid="awac123-B3" ref-type="bibr">3</xref></sup></p>
      <p>The significant molecular heterogeneity of HSP is indicative of a complex pathomolecular
aetiology, which remains poorly understood with genes associated with the condition being
implicated in a wide array of cellular processes. These include protection against oxidative
stress, DNA repair, metabolism of neuroprotective steroids, myelin sheath stabilization,
axonal growth and subcellular transport,<sup><xref rid="awac123-B4" ref-type="bibr">4</xref></sup> all proposed to lead to axonal failure and progressive lower-limb
spasticity characteristic of the condition.<sup><xref rid="awac123-B1" ref-type="bibr">1</xref>,<xref rid="awac123-B3" ref-type="bibr">3</xref></sup> Recently, increasing
genetic and molecular evidence suggests a potential central role for aberrant lipid
metabolic processes in particular involving endoplasmic reticulum (ER), mitochondria and
other organelles.<sup><xref rid="awac123-B2" ref-type="bibr">2</xref></sup> Many of the
genes associated with motor neuron degenerative diseases, including HSP, have been linked in
molecular studies with lipid metabolic pathways, in particular involving molecular flux
between the ER and mitochondria. ER and mitochondrial compartments connect via
mitochondria-ER contact sites (MERCs),<sup><xref rid="awac123-B2" ref-type="bibr">2</xref></sup> which are distinct structural domains characterized by the close
apposition of both ER and mitochondrial membranes, and establish a molecular platform
crucial for signalling and metabolite flux between both organelles in order to maintain
organelle and cellular homeostasis.<sup><xref rid="awac123-B5" ref-type="bibr">5&#x2013;7</xref></sup> The ER is the main site of phospholipid biosynthesis
and provides lipid precursors to other membranes, including mitochondria.<sup><xref rid="awac123-B8" ref-type="bibr">8</xref>,<xref rid="awac123-B9" ref-type="bibr">9</xref></sup> Phospholipid transport from the ER to mitochondria via MERCs enables the
synthesis of essential mitochondrial phospholipids including cardiolipin, phosphatidylserine
and phosphatidylethanolamine.<sup><xref rid="awac123-B10" ref-type="bibr">10</xref></sup>
These molecular pathways provide the essential building blocks of biological membranes, and
alterations in genes encoding the proteins regulating these pathways have been linked with
HSP.<sup><xref rid="awac123-B2" ref-type="bibr">2</xref>,<xref rid="awac123-B10" ref-type="bibr">10&#x2013;12</xref></sup> Thus,
maintaining MERCs integrity is increasingly recognized as being critical for phospholipid
metabolism and also cellular homeostasis more widely,<sup><xref rid="awac123-B13" ref-type="bibr">13</xref></sup> and gene alterations leading to impaired MERCs function
probably form a molecular theme common to many neurological disorders.<sup><xref rid="awac123-B2" ref-type="bibr">2</xref>,<xref rid="awac123-B14" ref-type="bibr">14</xref></sup></p>
      <p>The osmosensitive calcium (OSCA)/transmembrane protein 63 (TMEM63) protein family members
entail a newly identified family of mechanical ion channels activated by membrane tension,
which are conserved across eukaryotes.<sup><xref rid="awac123-B15" ref-type="bibr">15</xref></sup> The family comprises three members: <italic toggle="yes">TMEM63A</italic>,
<italic toggle="yes">TMEM63B</italic> and <italic toggle="yes">TMEM63C</italic>, the function of which has not been
extensively explored in mammals. Zhao <italic toggle="yes">et al</italic>.<sup><xref rid="awac123-B16" ref-type="bibr">16</xref></sup> identified a possible role of <italic toggle="yes">TMEM63</italic>
proteins as osmoreceptor transduction channels, and found that expression of all three
members was required in cell transfection studies for channel activity. Studies on
<italic toggle="yes">TMEM63C</italic> plant orthologues (AtCSC1 and OSCA1) indicate that it may indeed
function as a Ca<sup>2+</sup> permeable cation channel that is activated by hyperosmotic
stress.<sup><xref rid="awac123-B15" ref-type="bibr">15</xref>,<xref rid="awac123-B16" ref-type="bibr">16</xref></sup> While previous studies of TMEM63C are restricted to its
plant orthologues, maintenance of the ionic and osmotic composition and volume of fluids is
crucial for the normal functioning of the brain,<sup><xref rid="awac123-B17" ref-type="bibr">17</xref></sup> of clear relevance should the mammalian (and human)
<italic toggle="yes">TMEM63C</italic> orthologues possess similar functionalities. Interestingly,
studying the structure of ER-localized OSCA1.2, a plant orthologue of
<italic toggle="yes">TMEM63C</italic>, revealed striking topological similarities with the
transmembrane protein <italic toggle="yes">TMEM16.</italic><sup><xref rid="awac123-B18" ref-type="bibr">18</xref>,<xref rid="awac123-B19" ref-type="bibr">19</xref></sup> Dysfunction of
different TMEM16 proteins (also known as anoctamins) is associated with several neurologic
disorders, including muscle disease, cerebellar ataxia and dystonia.<sup><xref rid="awac123-B20" ref-type="bibr">20</xref></sup> Importantly, one member of this
family, TMEM16K, has been proposed to regulate endosomal function at ER-endosome contact
sites. Furthermore, the yeast TMEM16 orthologue, Ist2p, is a tether protein connecting the
ER and the plasma membrane, identifying a role of some TMEM16 family members at membrane
contact sites.<sup><xref rid="awac123-B21" ref-type="bibr">21</xref>,<xref rid="awac123-B22" ref-type="bibr">22</xref></sup> Here we present genetic, clinical and molecular data
that identify biallelic variants in <italic toggle="yes">TMEM63C</italic> probably leading to loss of
function, as a cause of both pure and complex HSP. Our molecular studies determine that
TMEM63C is an ER-localized protein enriched at MERCs, and that <italic toggle="yes">TMEM63C</italic>
knockdown is associated with mitochondrial and ER morphological defects, revealing a
previously unidentified role of TMEM63C in mediating organelle homeostasis.</p>
    </sec>
    <sec sec-type="materials|methods" id="awac123-s2">
      <title>Materials and methods</title>
      <sec id="awac123-s2.1">
        <title>Clinical studies</title>
        <p>All research was performed with informed consent from the study participants or their
legal guardians, and according to institutional and international guidelines for studies
with human subjects and materials (approved protocols; RC/SCI/BIOL/10/01 and EE/97.24.3
17654/scu.ac, ir). Affected individuals were investigated according to routine clinical
standards for the diagnosis of neurological disease.</p>
      </sec>
      <sec id="awac123-s2.2">
        <title>Genetic studies</title>
        <p>DNA was extracted from blood using standard techniques. Single nucleotide polymorphism
(SNP) genotyping was carried out on DNA from both affected individuals from Family 1
(IV:2, IV:8), using Illumina Human CytoSNP-12v2.1 arrays.</p>
        <p>In all three families, whole exome sequencing (WES) was undertaken to identify the cause
of disease. Genomic variants were filtered based on call quality, impact on gene function,
allele frequency in the population databases and segregation with disease. Variants were
then assessed for clinical correlation with the affected individual(s) phenotype. In
Family 1, WES was performed in Exeter on DNA from affected Individual IV:2 (NextSeq500;
Illumina, San Diego, CA, USA) and involved Agilent Sureselect Whole Exome v.6 (Agilent
Technologies, Santa Clara, CA, USA) targeting, read alignment (BWA-MEM v.0.7.17),
mate-pairs fixed and duplicates removed (Picard v.2.15), InDel realignment and base
quality recalibration (GATK v.3.7.0), single nucleotide variant and InDel detection (GATK
HaplotypeCaller), variant annotation [Alamut batch v.1.10 and SnpEff (<ext-link xlink:href="http://snpeff.sourceforge.net/SnpEff_manual.html" ext-link-type="uri">http://snpeff.sourceforge.net/SnpEff_manual.html</ext-link>)] and read depth assessment
(equivalent to GATK DepthOfCoverage). Copy number variants (CNVs) were detected using
SavvyCNV. Variants with &lt;5 reads and/or a frequency &gt;0.1% in public genome databases
including the Genome Aggregation Database (gnomAD v2.1.1) and the 1000 Genomes Project
were excluded. Homozygous and compound heterozygous variants that were exonic and
non-synonymous, synonymous with predicted splicing impact or intronic at &#xB1;6 nucleotides
from splice site were evaluated and cross referenced against the SNP data. In Family 2,
WES (VI:2) and genome-wide SNP genotyping (affected Individuals: V:I, V:II, VI:I, VI:II)
were performed in parallel as previously described.<sup><xref rid="awac123-B23" ref-type="bibr">23</xref></sup> Variants were prioritized by call quality and
frequency &lt;0.1% (gnomAD v.2.1.1) and cross referenced against the SNP data. The variant
filtering steps followed in Family 2 were otherwise similar to those described previously.
In Family 3, duo WES was performed on DNA from the proband (II:1) and her mother (NextSeq
500 Sequencing System, Illumina, San Diego, USA), with a 2&#x2009;&#xD7;&#x2009;150&#x2005;bp high output sequencing
kit after 12-plex enrichment with SeqCap EZ MedExome kit (Roche). Sequence quality was
assessed with FastQC v.0.11.5 and reads mapped and indexed [BWA-MEM (v.0.7.13 and Samtools
v.1.4.1)], duplicates flagged (Sambamba v.0.6.6) and coverage calculated (Picard tools
v.2.10.10). SNVs/InDels calling was performed using GATK 3.7 Haplotype Caller and CNV
detection with CNVKit and Excavator2, variants were annotated using Annovar. The variant
filtering steps followed were similar to those described for Family 1.</p>
        <p>Unique primers were designed and used for dideoxy sequencing confirmation and
cosegregation of genomic variants.</p>
      </sec>
      <sec id="awac123-s2.3">
        <title>Molecular and cellular studies</title>
        <sec id="awac123-s2.3.1">
          <title>Cell culture and transfections</title>
          <p>HeLa and SH-SY5Y cells were obtained from American Type Culture Collection and NSC-34
cells from Cedarlane Laboratories (via tebu-bio). HeLa and NSC-34 cells were cultured in
Dulbecco&#x2019;s modified Eagle medium (DMEM) (GIBCO) and SH-SY5Y cells in DMEM/F12 medium
(GIBCO), all supplemented with high-glucose (5&#x2005;g.l<sup>&#x2212;1</sup>), 10% foetal bovine
serum (FBS), 2&#x2005;mM <sc>l</sc>-glutamine, 1% non-essential amino acids and 100&#x2005;units/ml
penicillin/streptomycin (all from GIBCO). Cells were maintained at 37&#xB0;C with 5%
CO<sub>2</sub>. NSC-34 cells were differentiated into neurons by maintaining them in
DMEM/F12 medium supplemented with 1% FBS, 1% non-essential amino acids and 10&#x2005;&#x3BC;M
retinoic acid (Scientific Laboratory Supplies) for 14 days.<sup><xref rid="awac123-B24" ref-type="bibr">24</xref></sup></p>
          <p>Cells at 80% of confluence were transfected for 24&#x2005;h using Fugene HD transfection
reagent (Promega) following the manufacturers&#x2019; instructions. For small interference (si)
RNA experiments, cells were reverse transfected using Lipofectamine RNAimax (Invitrogen)
with 20&#x2005;nM siRNA for 3&#x2005;days, following the manufacturer&#x2019;s instructions. Media was
changed 6 and 24&#x2005;h after plasmid and siRNA transfections, respectively. NSC-34 cells
were silenced after 8&#x2005;days of differentiation for 6&#x2005;days with 20&#x2005;nM siRNA, by performing
two consecutive rounds of reverse transfection with Lipofectamine RNAimax (one every
3&#x2005;days). Cells were tested for mycoplasma contamination using the Lookout Mycoplasma PCR
detection kit (Sigma).</p>
        </sec>
        <sec id="awac123-s2.3.2">
          <title>siRNA oligonucleotides and plasmids</title>
          <p>The following siRNAs were obtained from Dharmacon: non-targeting siRNA (siNT)
(ONTARGETplus SMARTpool D-0001810-10-20), siRNA targeting human <italic toggle="yes">TMEM63C</italic>
(siTMEM63C) (ONTARGETplus SMARTpool L-021981-02-0005) and siRNA targeting mouse
<italic toggle="yes">TMEM63C</italic> (siTMEM63C) (ONTARGETplus SMARTpool L-055603-01-0005). IDT
codon optimization tool was used to design a Gblock containing the full sequence of
TMEM63C including a Flag sequence at the C-terminal region and extensions to the 5&#x2032; and
3&#x2032; ends to enable In-Fusion cloning technology (Takara). The insert was introduced into
a pcDNA3.1(+) plasmid at the KpnI and XbaI restriction sites. pcDNA3.1(+) backbone
(empty vector) was used as control.</p>
        </sec>
        <sec id="awac123-s2.3.3">
          <title>Antibodies</title>
          <p>The following primary antibodies and dilutions were used for immunofluorescence
studies: mouse anti-Flag (Sigma-Aldrich, F3165) (1:1000), rabbit anti-TOM20 (Santa-Cruz,
sc11415) (1:1000), rabbit anti-PMP70 (Sigma-Aldrich, SAB4200181) (1:1000), mouse
anti-p230 (BD Biosciences, 611281) (1:1000), rabbit anti-Rab7 (Abcam, ab137029)
(1:1000), rat anti-Calnexin (Biolegend, 699401) (1:1000) and mouse anti-Neurofilament H
(Biolegend, 835801). Donkey anti-mouse, Goat anti-mouse IgG1, Goat anti-mouse IgG2a,
Goat anti-rabbit and Goat anti-rat, Alexa Fluor 488, 568 or 647 were used as secondary
antibodies (1:1000) (Invitrogen).</p>
          <p>The following primary antibodies and dilutions were used for immunoblot analysis: mouse
anti-Flag (Sigma-Aldrich, F3165) (1:1000), mouse anti-VDAC1 (Abcam, ab14734) (1:1000),
rabbit anti-TMEM63C (Abcam, ab203486) (1:500), rabbit anti-Pex14 (Proteintech,
10594-1-AP) (1:1000), rabbit anti-Calnexin (Proteintech, 10427-1-AP) (1:1000), mouse
anti-Tubulin (Santa-Cruz, sc23948) (1:1000), rabbit anti-VAPB (Atlas, HPA013144) (1:500)
and mouse anti-ACSL4 (Santa-Cruz, sc-365230) (1:1000). Horseradish peroxidase-conjugated
anti-rabbit and anti-mouse IgG (GE Healthcare) were used as secondary antibodies
(1:3000).</p>
        </sec>
        <sec id="awac123-s2.3.4">
          <title>SDS&#x2013;PAGE and immunoblotting</title>
          <p>Cells were lysed in RIPA buffer (20&#x2005;mM Tris pH 8.0, 150&#x2005;mM NaCl, 0.1% SDS, 1%
deoxycholic acid, 1% NP-40 and complete protease inhibitor cocktail). Protein
concentration of the samples was measured using Bradford protein assay (BioRad)
calibrated using a bovine serum albumin standard curve. Proteins were resolved by sodium
dodecyl sulphate&#x2013;polyacrylamide gel electrophoresis (SDS&#x2013;PAGE) and then transferred to
nitrocellulose membranes (0.2&#x2005;&#x3BC;m pore size, GE Healthcare). Membranes were blocked with
5% of skimmed milk in PBS for 1&#x2005;h at room temperature to block non-specific epitopes.
Membranes were then incubated with the appropriate primary antibodies diluted in 2%
milk-PBS-0.05% Tween-20 at 4&#xB0;C overnight. Membranes were washed in 0.05% Tween-20 in PBS
three times for 15&#x2005;min and incubated with appropriate secondary antibodies (1/3000 in 2%
Milk-0.05% Tween-20 in PBS) and treated with Western Lightning Plus ECL (Perkin Elmer).
Chemiluminescent signal was captured using films (PROTEC&#xAE;) or on a digital ECL machine
(Amersham). Uncropped immunoblots for all the experiments presented in the figures are
displayed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig.
4</xref>.</p>
        </sec>
        <sec id="awac123-s2.3.5">
          <title>Immunofluorescence</title>
          <p>Immunofluorescence experiments were performed as previously described.<sup><xref rid="awac123-B25" ref-type="bibr">25</xref></sup> Briefly, cells were fixed in 5%
paraformaldehyde (PFA) in PBS at 37&#xB0;C for 15&#x2005;min, then washed three times with PBS,
followed by incubation with 50&#x2005;mM ammonium chloride in PBS to quench the unspecific
fluorescence signal from aldehyde groups. Cells were washed again three times with PBS
and permeabilized in 0.1% Triton X-100 in PBS for 10&#x2005;min. Then, cells were blocked with
10% FBS in PBS, followed by incubation with the appropriate primary antibodies in 5% FBS
in PBS, for 2&#x2005;h at room temperature. After three washes with 5% FBS in PBS, cells were
incubated with specific secondary antibodies (1:1000) for 1&#x2005;h at room temperature. After
three washes in PBS, coverslips were mounted onto slides using Dako fluorescence
mounting medium (Dako) (confocal imaging) or ProLong<sup>TM</sup> Diamond Antifade
(Thermo) (super-resolution imaging). For nuclear staining, coverslips were mounted using
ProLong&#x2122; Gold Antifade Mounting with DAPI (Thermo).</p>
        </sec>
        <sec id="awac123-s2.3.6">
          <title>Confocal and N-structured illumination microscopy image acquisition</title>
          <p>For confocal imaging, fixed and stained cells were visualized and acquired using a &#xD7;100
objective lens (numerical aperture 1.4) on a Nikon Eclipse TiE inverted microscope with
appropriate lasers using an Andor Dragonfly 500 spinning disc system, equipped with a
Zyla 4.2 PLUS sCMOS camera (Andor), coupled with Fusion software (Andor). For TMEM63C
co-localization, mitochondrial and ER morphology analysis, seven stacks of 0.2&#x2005;&#x3BC;m each
were acquired using the &#xD7;100 objective and then compiled by &#x2018;max projection&#x2019; using the
Fiji software. Mitochondrial morphology was analysed and presented as intermediate,
elongated or fragmented, as described previously.<sup><xref rid="awac123-B26" ref-type="bibr">26</xref></sup> Mitochondria were classified as &#x2018;fragmented&#x2019; when
most of the mitochondria of the cell were short and spherical, &#x2018;elongated&#x2019; when most of
the mitochondria of the cell presented highly elongated mitochondria with &lt;10 free
ends, and &#x2018;intermediate&#x2019; when most of the mitochondria of the cell were tubular, neither
connected or spherical. For N-Structure Illumination Microscopy super-resolution
imaging, fixed samples were observed under a Nikon Eclipse Ti-E microscope equipped with
an Andor iXon camera coupled with a Nikon N-SIM attachment. Seven stacks of 0.2&#x2005;&#x3BC;m each
were acquired using the &#xD7;100 objective coupled with Nis-Elements AR 5.21.03
software.</p>
          <p>The different mitochondrial parameters (length, area, number and number of junctions)
were quantified by randomly selecting regions of interest of 225&#x2005;&#x3BC;m<sup>2</sup> at the
cell periphery and analysed using MitoMapr (Fiji).<sup><xref rid="awac123-B27" ref-type="bibr">27</xref></sup> For ER quantification, the total area of the cell
and the area covered by ER sheet were manually selected using Fiji tools. Fiji macro
(JaCOP) was used to measure Mander&#x2019;s coefficient of co-localization between the ER and
mitochondria. At least 15 cells per condition were analysed; three independent
experiments. All the representative images were processed once with the &#x2018;smooth&#x2019;
function in Fiji. The number of cells analysed in the corresponding figures are: <xref rid="awac123-F3" ref-type="fig">Fig. 3B</xref> (siNT&#x2009;=&#x2009;60 cells, siTMEM63C&#x2009;=&#x2009;62
cells), <xref rid="awac123-F3" ref-type="fig">Fig. 3D</xref> (siNT&#x2009;=&#x2009;105 cells,
siTMEM63C&#x2009;=&#x2009;93 cells), <xref rid="awac123-F3" ref-type="fig">Fig. 3E</xref> (siNT&#x2009;=&#x2009;76
cells, siTMEM63C&#x2009;=&#x2009;78 cells), <xref rid="awac123-F3" ref-type="fig">Fig. 3G and H</xref>
[TMEM63C-Flag (&#x2212;)&#x2009;=&#x2009;45 cells, TMEM63C-Flag (+)&#x2009;=&#x2009;45 cells], <xref rid="awac123-F3" ref-type="fig">Fig. 3J</xref> (siNT&#x2009;=&#x2009;98 axons, siTMEM63C&#x2009;=&#x2009;101 axons), <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3C</xref> (siNT&#x2009;=&#x2009;72
cells, siTMEM63C&#x2009;=&#x2009;66 cells), <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3D</xref> (siNT&#x2009;=&#x2009;57 cells, siTMEM63C&#x2009;=&#x2009;55 cells) and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3F</xref> (siNT&#x2009;=&#x2009;63
cells, siTMEM63C&#x2009;=&#x2009;60 cells).</p>
          <fig position="float" id="awac123-F3" fig-type="figure">
            <label>Figure 3</label>
            <caption>
              <p>
<bold>TMEM63C silencing alters both ER and mitochondrial morphologies.</bold>
(<bold>A</bold>) Representative confocal images of ER morphology of control (siNT)
and <italic toggle="yes">TMEM63C</italic> (siTMEM63C) silenced HeLa cells. ER and mitochondria
were labelled with anti-Calnexin and anti-TOM20 antibodies, respectively. Scale
bars&#x2009;=&#x2009;10&#x2005;&#xB5;m. (<bold>B</bold>) Quantification of ER morphology related to
<bold>A</bold>. (<bold>C</bold>) Representative confocal images of mitochondrial
morphology of control (siNT) and <italic toggle="yes">TMEM63C</italic> (siTMEM63C) silenced HeLa
cells. Mitochondria were labelled using an anti-TOM20 antibody. Scale bars&#x2009;=&#x2009;10&#x2005;&#xB5;m.
(<bold>D</bold>) Quantification of mitochondrial morphology related to
<bold>C</bold>. (<bold>E</bold>) Quantification of different mitochondrial
morphology parameters including mean mitochondrial length and area, mitochondrial
number and mitochondrial branching measured by mitochondrial junction number, per
region of interest of 225&#x2005;&#xB5;m<sup>2</sup>, related to <bold>C</bold>.
(<bold>F</bold>) Representative confocal images of mitochondrial morphology of
TMEM63C-Flag overexpressing HeLa cells, compared to untransfected cells. Flag and
mitochondria were labelled with anti-Flag and anti-TOM20 antibodies, respectively.
Scale bars&#x2009;=&#x2009;10&#x2005;&#xB5;m. (<bold>G</bold>) Quantification of mitochondrial morphology
related to <bold>F</bold>. (<bold>H</bold>) Quantification of different
mitochondrial morphology parameters including mean mitochondrial length and area,
mitochondrial number and mitochondrial branching measured by mitochondrial junction
number, per region of interest of 225&#x2005;&#xB5;m<sup>2</sup>, related to <bold>F</bold>.
(<bold>I</bold>) Representative confocal images of axonal mitochondria from
control (siNT) and <italic toggle="yes">TMEM63C</italic> (siTMEM63C) silenced differentiated
motor neuron-like NSC-34 cells. Mitochondria were labelled using an anti-TOM20
antibody and axons were recognized using an anti-Neurofilament H antibody. Scale
bars&#x2009;=&#x2009;10&#x2005;&#xB5;m. (<bold>J</bold>) Quantification of axonal mitochondrial length related
to <bold>I</bold>. All data are shown as mean&#x2009;&#xB1;&#x2009;SD of at least three independent
experiments. For <bold>D</bold> and <bold>G</bold>, two-way ANOVA and Tukey&#x2019;s
multiple-comparisons test was used; for <bold>B</bold>, <bold>E</bold>,
<bold>H</bold> and <bold>J</bold>, Mann&#x2013;Whitney U-test (two-tailed) was used.
*<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.05, **<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.01,
***<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.001, ****<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.0001.</p>
            </caption>
            <graphic xlink:href="awac123f3" position="float"/>
          </fig>
        </sec>
        <sec id="awac123-s2.3.7">
          <title>Respirometry</title>
          <p>Oxygen consumption measurements were performed in intact cells resuspended in culture
DMEM medium using an Oroboros Instruments High-Resolution Respirometer.<sup><xref rid="awac123-B28" ref-type="bibr">28</xref></sup> Approximately 3&#x2009;&#xD7;&#x2009;10<sup>6</sup>
cells were used for each experiment. Basal (ROUTINE) respiration was recorded until the
steady state was reached. The non-phosphorylating respiration (LEAK) was measured adding
2.5&#x2005;&#x3BC;M oligomycin to the chambers to inhibit the ATP synthase and the respiration rates
were left to reach the steady state. The uncoupled state or maximal capacity of the
electron transfer system was achieved by titrating CCCP in 0.5&#x2005;&#x3BC;M steps until the
respiratory rates did not increase any further. Finally, 2.5&#x2005;&#x3BC;M antimycin A and 1&#x2005;&#x3BC;M
rotenone were added to inhibit respectively complex III and complex I.
<italic toggle="yes">n</italic>&#x2009;=&#x2009;four independent experiments.</p>
        </sec>
        <sec id="awac123-s2.3.8">
          <title>Mitochondrial-associated membrane isolation</title>
          <p>Mitochondrial-associated membrane (MAM) isolation was performed as described
previously.<sup><xref rid="awac123-B29" ref-type="bibr">29</xref></sup> Briefly,
HeLa cells were trypsinized, pelleted at 300<italic toggle="yes">g</italic> and washed in 1&#xD7; PBS, pH
7.4. All the following centrifugations were performed at +4&#xB0;C. Pellets were resuspended
in prechilled mitochondria isolation buffer (MIB) (220&#x2005;mM mannitol, 70&#x2005;mM sucrose, 10&#x2005;mM
Tris-KOH pH 7.4, 1&#x2005;mM EDTA) with protein cocktail inhibitor and homogenized in a manual
glass mortar (Kimble). Homogenates were centrifuged at 800<italic toggle="yes">g</italic>.
Supernatants were centrifuged at 2300<italic toggle="yes">g</italic> with pellets washed in MIB and
collected as the crude mitochondrial fraction. Additional centrifugation at
8000<italic toggle="yes">g</italic> was performed. Supernatants were then centrifuged at
100&#x2009;000<italic toggle="yes">g</italic> for 60&#x2005;min and cytosolic (supernatant) and microsomal
(pellet) fractions were obtained. The crude mitochondrial fraction was then resuspended
in MIB buffer, layered on 30% Percoll solution and centrifuged at
95&#x2009;000<italic toggle="yes">g</italic> for 65&#x2005;min. MAM and pure mitochondrial fraction were
extracted with 20-gauge needles. MAM and pure mitochondrial fraction were then washed in
ice-cold 1&#xD7; PBS, pH 7.4 and centrifuged at 6300<italic toggle="yes">g</italic> and
10&#x2009;000<italic toggle="yes">g</italic> for 20&#x2005;min for MAM and pure mitochondrial fraction,
respectively. All fractions were extracted with MIB 1% Triton X-100, normalized for
protein content and processed for SDS&#x2013;PAGE and immunoblotting.</p>
        </sec>
        <sec id="awac123-s2.3.9">
          <title>Statistical analysis</title>
          <p>Errors bars displayed on graphs represent the mean&#x2009;&#xB1;&#x2009;SD from at least three independent
experiments. Statistical significance was analysed using Mann&#x2013;Whitney U-test
(two-tailed), unpaired <italic toggle="yes">t</italic>-test (two-tailed) or two-way ANOVA test using
GraphPad Prism software. *<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.05, **<italic toggle="yes">P</italic> &#x2009;&lt;&#x2009;0.01,
***<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.001 and ****<italic toggle="yes">P</italic>&#x2009;&lt;&#x2009;0.0001 were
considered significant.</p>
        </sec>
      </sec>
      <sec sec-type="data-availability" id="awac123-s2.4">
        <title>Data availability</title>
        <p>The authors confirm that the data supporting the findings of this study are available
within the article and <xref rid="sup1" ref-type="supplementary-material">Supplementary
material</xref>. Further derived data are available from the corresponding author upon
reasonable request.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="awac123-s3">
      <title>Results</title>
      <sec id="awac123-s3.1">
        <title>Clinical and genetic studies</title>
        <p>We initially investigated the cause of disease in two male Omani siblings (Family 1-IV:2
and IV:8) (<xref rid="awac123-F1" ref-type="fig">Fig. 1</xref>) affected by HSP associated
with mild intellectual impairment. The older male (IV:2) was late to walk and presented at
19 months of age with lower-limb spasticity and weakness. Although his phenotype was
initially thought to be pure HSP, he was later noted to be microcephalic (&#x2212;3.78 SD) and to
be cognitively impaired [Stanford Binet Intelligence Scale (IQ) score of 61 (attained
mental age of 7 years 6 months at a chronological age of 11 years 4 months)]. Upper limb
reflexes, motor function and sensation were all unaffected and there was no clinical
evidence of bulbar involvement. Lower-limb nerve conduction studies (NCS) and MRI were
performed and were unremarkable. The younger brother (IV:8), followed a very similar
clinical course. The earliest sign of neurological impairment was delayed motor milestones
(crawled at 12 months, independent walking 22 months) and toe walking. At age 3 years, he
had progressive lower-limb spastic weakness and mild global developmental delay with
limited vocabulary and language processing skills. To identify the genetic cause of HSP,
genome-wide SNP mapping was undertaken on DNA from both affected brothers (IV:2 and IV:8)
in parallel with WES in IV:2, assuming homozygosity for a founder mutation was most
probably responsible, although also considering other possible genetic causes. As expected
in this family structure, autozygosity mapping identified 14 genomic regions &gt;1&#x2005;Mb
common to both affected siblings, among the largest being a &#x223C;10&#x2005;Mb region on chromosome
14q24 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 1</xref>).
WES identified a homozygous [Chr14 (GRCh37):77,714,729-744delinsGGC;
NM_020431.3:c.1641_1656delinsGGC; NM_020431.3: p.(Asn547Lysfs*42)] variant in the
transmembrane protein 63C (<italic toggle="yes">TMEM63C</italic>) gene as the most likely cause of
disease, located within the shared chromosome 14q24 genomic region. The variant, which is
not listed in gnomAD v.2.1.1 or v.3.1.1 nor in our in-house ancestry-matched Omani
database of 1562 whole exomes, is predicted to cause a frameshift beginning at codon
asparagine 547 leading to a premature stop codon 42 amino acids subsequently
[p.(Asn547Lysfs*42)]. Other variants that could not be excluded in this family are listed
in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>.</p>
        <fig position="float" id="awac123-F1" fig-type="figure">
          <label>Figure 1</label>
          <caption>
            <p>
<bold>Family pedigrees and biallelic <italic toggle="yes">TMEM63C</italic> variants identified as a
cause of HSP</bold>. (<bold>A</bold>) Family 1: Extended Omani pedigree in which two
affected individuals are homozygous for the Chr14(GRCh37):77714729-744delinsGGC;
NM_020431.3:c.1641_1656delinsGGC; NM_020431.3:p.(Asn547Lysfs*42) variant. Family 2:
Extended Iranian pedigree including two nuclear families with a total of four affected
individuals homozygous for the Chr14(GRCh37):g.77709274delT, NM_020431.3, c.1216delT,
p.(Trp406Glyfs*26) variant. Family 3: North African pedigree with one affected
individual compound heterozygous for both p.(Tyr195*) and p.(Tyr525Leufs*54) variants.
Cosegregation confirmed in other family members as indicated, in each case &#x2018;+&#x2019;
indicating variant allele and &#x2018;&#x2212;&#x2019; indicating wild-type allele (paternal genotype
inferred in Family 3, indicated by genotyping shown in parentheses). (<bold>B</bold>)
Dideoxy sequence chromatogram of an affected individual from each pedigree showing
variant alleles. (<bold>C</bold>) Schematic diagram of the TMEM63C gene showing
intron/exon genomic organization and the location of <italic toggle="yes">TMEM63C</italic> gene
variants. (<bold>D</bold>) Schematic diagram of the TMEM63C polypeptide showing
location of the variants identified with regard to protein domain architecture.
Protein domains: RSN1_TM&#x2009;=&#x2009;late exocytosis, associated with Golgi transport,
PHM7_cyt&#x2009;=&#x2009;cytosolic domain of 10TM putative phosphate transporter, RSN1_7TM&#x2009;=&#x2009;RSN1_7
calcium-dependent channel, seven transmembrane region.</p>
          </caption>
          <graphic xlink:href="awac123f1" position="float"/>
        </fig>
        <p>Family 2, an extended Iranian family, comprises two nuclear families each with two
siblings diagnosed with HSP (Family 2-VI:1, VI:2, V:1, V:2) (<xref rid="awac123-F1" ref-type="fig">Fig. 1</xref>). All four affected individuals presented with delayed
motor development and displayed progressive lower-limb spasticity with associated
hyper-reflexia, upgoing plantar responses, clonus and muscle weakness. This resulted in a
narrow-based spastic gait and excessive lordosis in Individual VI:1 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Video 1</xref>). There was no
evidence of upper limb involvement on examination of VI:1 and VI:2. Ophthalmological
findings included strabismus (VI:2) and horizontal nystagmus (V:1). Both affected
Individuals VI:1 and V:1 have a mild stutter. Siblings VI:1 and VI:2 have normal
intellect, whereas both V:1 and V:2 displayed signs of mild intellectual impairment. MRI,
NCS and electromyography were undertaken as part of VI:1 and VI:2&#x2019;s clinical
investigations and were unremarkable. Exome sequencing undertaken on DNA from VI:2
identified a homozygous [Chr14(GRCh37): g.77709274delT, NM_020431.3, c.1216delT,
p.(Trp406Glyfs*26)] variant in <italic toggle="yes">TMEM63C</italic>, predicted to cause a frameshift
beginning at codon 406 and leading to a premature stop codon 26 amino acids downstream, as
the only candidate causative mutation after correlation with the genome-wide SNP mapping
data. The variant is not present in either gnomAD v.2.1.1 or v.3.1.1 and is located in a
9.2&#x2005;Mb region of homozygosity on chromosome 14q24.3 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 1</xref>).</p>
        <p>Following these findings in Families 1 and 2, we next explored GeneMatcher and identified
a north African family (Family 3) (<xref rid="awac123-F1" ref-type="fig">Fig. 1</xref>)
with a single female (Family 3-II:1) affected with HSP diagnosed in early childhood. At
age 20 years she has mild intellectual impairment and remains ambulatory. WES identified
compound heterozygous Chr14(GRCh37): g.77703009C&#x2009;&gt;&#x2009;G, NM_020431.3:c.585C&#x2009;&gt;&#x2009;G,
p.(Tyr195*) and Chr14(GRCh37) and g.77712988dup, NM_020431.3:c.1572dup,
p.(Tyr525Leufs*54), probable loss of function variants in <italic toggle="yes">TMEM63C</italic>, both
absent in gnomAD v.2.1.1 and 3.1.1.</p>
        <p>In all three pedigrees the TMEM63C variants were validated by dideoxy sequencing and
found to cosegregate in all available family members as appropriate for autosomal
recessive inheritance (<xref rid="awac123-F1" ref-type="fig">Fig. 1</xref>) (see <xref rid="awac123-T1" ref-type="table">Table 1</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 1</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref> for detailed
clinical summaries, genome-wide SNP mapping data and WES variant lists).</p>
        <table-wrap position="float" id="awac123-T1">
          <label>Table 1</label>
          <caption>
            <p>Clinical findings in affected individuals with biallelic <italic toggle="yes">TMEM63C</italic>
variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="center" span="1"/>
              <col valign="top" align="center" span="1"/>
              <col valign="top" align="center" span="1"/>
              <col valign="top" align="center" span="1"/>
              <col valign="top" align="center" span="1"/>
              <col valign="top" align="center" span="1"/>
              <col valign="top" align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Family</th>
                <th colspan="2" align="center" rowspan="1">Family 1</th>
                <th colspan="4" align="center" rowspan="1">Family 2</th>
                <th align="center" rowspan="1" colspan="1">Family 3</th>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1">Pedigree reference</th>
                <th align="center" rowspan="1" colspan="1">IV:2</th>
                <th align="center" rowspan="1" colspan="1">IV:8</th>
                <th align="center" rowspan="1" colspan="1">VI:1</th>
                <th align="center" rowspan="1" colspan="1">VI:2</th>
                <th align="center" rowspan="1" colspan="1">V:1</th>
                <th align="center" rowspan="1" colspan="1">V:2</th>
                <th align="center" rowspan="1" colspan="1">II:1</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Genotype</td>
                <td colspan="2" rowspan="1">p.(Asn547Lysfs*42)/p.(Asn547Lysfs*42)</td>
                <td colspan="4" rowspan="1">p.(Trp406Glyfs*26)/p.(Trp406Glyfs*26)</td>
                <td rowspan="1" colspan="1">p.(Tyr195*)/p.(Tyr525Leufs*54)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Gender</td>
                <td rowspan="1" colspan="1">Male</td>
                <td rowspan="1" colspan="1">Male</td>
                <td rowspan="1" colspan="1">Male</td>
                <td rowspan="1" colspan="1">Female</td>
                <td rowspan="1" colspan="1">Male</td>
                <td rowspan="1" colspan="1">Male</td>
                <td rowspan="1" colspan="1">Female</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Ethnicity</td>
                <td rowspan="1" colspan="1">Omani</td>
                <td rowspan="1" colspan="1">Omani</td>
                <td rowspan="1" colspan="1">Iranian</td>
                <td rowspan="1" colspan="1">Iranian</td>
                <td rowspan="1" colspan="1">Iranian</td>
                <td rowspan="1" colspan="1">Iranian</td>
                <td rowspan="1" colspan="1">North African</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Age at evaluation (years)</td>
                <td rowspan="1" colspan="1">17</td>
                <td rowspan="1" colspan="1">3</td>
                <td rowspan="1" colspan="1">8</td>
                <td rowspan="1" colspan="1">26</td>
                <td rowspan="1" colspan="1">30</td>
                <td rowspan="1" colspan="1">32</td>
                <td rowspan="1" colspan="1">15</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Age of symptom onset</td>
                <td rowspan="1" colspan="1">19 months</td>
                <td rowspan="1" colspan="1">18 months</td>
                <td rowspan="1" colspan="1">Infancy</td>
                <td rowspan="1" colspan="1">Infancy</td>
                <td rowspan="1" colspan="1">Infancy</td>
                <td rowspan="1" colspan="1">Infancy</td>
                <td rowspan="1" colspan="1">6 months</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">
<bold>Growth parameters</bold>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Height cm (SDS)</td>
                <td rowspan="1" colspan="1">165 (&#x2212;1.52)</td>
                <td rowspan="1" colspan="1">90 (&#x2212;1.49)</td>
                <td rowspan="1" colspan="1">118 (&#x2212;1.8)</td>
                <td rowspan="1" colspan="1">156 (&#x2212;1.3)</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">162 (&#x2212;0.03)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Weight kg (SDS)</td>
                <td rowspan="1" colspan="1">47.1 (&#x2212;2.29)</td>
                <td rowspan="1" colspan="1">11.5 (&#x2212;2.28)</td>
                <td rowspan="1" colspan="1">21 (&#x2212;1.52)</td>
                <td rowspan="1" colspan="1">55 (&#x2212;0.42)</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">67 (1.45)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Head circumference cm (SDS)</td>
                <td rowspan="1" colspan="1">50.5 (&#x2212;3.78)</td>
                <td rowspan="1" colspan="1">50.5 (&#x2212;0.69)</td>
                <td rowspan="1" colspan="1">51 (&#x2212;1.83)</td>
                <td rowspan="1" colspan="1">58 (1.79)</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">54.5 (&#x2212;0.45)</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">
<bold>Development</bold>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Intellectual disability</td>
                <td rowspan="1" colspan="1">Mild, IQ 62</td>
                <td rowspan="1" colspan="1">Mild</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">Mild</td>
                <td rowspan="1" colspan="1">Mild</td>
                <td rowspan="1" colspan="1">Mild</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Gross motor</td>
                <td rowspan="1" colspan="1">Delayed walking</td>
                <td rowspan="1" colspan="1">Crawled at 12 months, walked at 22 months</td>
                <td rowspan="1" colspan="1">Walked at 22 months</td>
                <td rowspan="1" colspan="1">Walked at 22 months</td>
                <td rowspan="1" colspan="1">Delayed walking</td>
                <td rowspan="1" colspan="1">Delayed walking</td>
                <td rowspan="1" colspan="1">Walked at 20 months</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Speech</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Limited vocabulary, only 2 words until 24 months</td>
                <td rowspan="1" colspan="1">Stuttering</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Stuttering</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Vision</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Strabismus</td>
                <td rowspan="1" colspan="1">Nystagmus</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Hearing</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
                <td rowspan="1" colspan="1">Normal</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Developmental regression</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">
<bold>Neurology</bold>
</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">Lower limb</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;Spasticity</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;Hyper-reflexia</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;Extensor plantars</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">+</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">Upper limb</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;Spasticity</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;Hyper-reflexia</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Cerebellar signs</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Dystonia</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">NK</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Dysarthria</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
                <td rowspan="1" colspan="1">&#x2212;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Gait</td>
                <td rowspan="1" colspan="1">Spastic</td>
                <td rowspan="1" colspan="1">Spastic</td>
                <td rowspan="1" colspan="1">Spastic</td>
                <td rowspan="1" colspan="1">Spastic</td>
                <td rowspan="1" colspan="1">Spastic</td>
                <td rowspan="1" colspan="1">Spastic</td>
                <td rowspan="1" colspan="1">Spastic</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Other clinical findings</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">Lumbar lordosis</td>
                <td rowspan="1" colspan="1">Lumbar lordosis</td>
                <td rowspan="1" colspan="1">Lumbar lordosis</td>
                <td rowspan="1" colspan="1">Lumbar lordosis</td>
                <td rowspan="1" colspan="1">Hypertonic urinary bladder disturbance</td>
              </tr>
              <tr>
                <td colspan="8" rowspan="1">
<bold>Investigations</bold>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">MRI brain</td>
                <td rowspan="1" colspan="1">NAD</td>
                <td rowspan="1" colspan="1">NP</td>
                <td rowspan="1" colspan="1">NAD</td>
                <td rowspan="1" colspan="1">NAD</td>
                <td rowspan="1" colspan="1">NP</td>
                <td rowspan="1" colspan="1">NP</td>
                <td rowspan="1" colspan="1">NP</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Other investigations</td>
                <td rowspan="1" colspan="1">NCS-NAD VEP-NAD BAEP-NAD</td>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">NCS-NAD EMG-NAD</td>
                <td rowspan="1" colspan="1">NCS-NAD EMG-NAD</td>
                <td colspan="3" rowspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="awac123-tblfn1">
              <p>NP&#x2009;=&#x2009;not performed; SDS&#x2009;=&#x2009;standard deviation score; (+)&#x2009;=&#x2009;indicates presence of a
feature in an affected individual; (&#x2212;)&#x2009;=&#x2009;indicates absence of a feature in an
affected individual; NK&#x2009;=&#x2009;not known; NAD&#x2009;=&#x2009;no abnormality detected; NCS&#x2009;=&#x2009;nerve
conduction studies; VEP&#x2009;=&#x2009;visual evoked potential; BAEP&#x2009;=&#x2009;brainstem auditory evoked
potential. Height, weight and standard deviation scores were calculated using a
Microsoft Excel add-in to access growth references based on the LMS method using UK
1990 reference population.<sup><xref rid="awac123-B30" ref-type="bibr">30</xref></sup></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="awac123-s3.2">
        <title>Molecular studies</title>
        <p>To gain an initial insight into the molecular function, a characterization of TMEM63C was
performed using two different mammalian cell lines: the HeLa cell line derived from
cervical cancer cells and the neuroblastoma SH-SY5Y cells, which both represent well
established models for molecular and cellular studies. First, we aimed to elucidate the
cellular distribution of TMEM63C. Since commercial antibodies did not work for
immunofluorescence staining, we developed a codon-optimized TMEM63C construct tagged with
a C-terminal FLAG epitope to analyse the intracellular localization of TMEM63C. While
TMEM63 family members have been proposed to be localized to the plasma membrane,<sup><xref rid="awac123-B15" ref-type="bibr">15</xref>,<xref rid="awac123-B31" ref-type="bibr">31</xref></sup> confocal microscopy analysis of TMEM63C-FLAG overexpressing HeLa
cells revealed expression at a specific intracellular location reminiscent of an ER
protein (<xref rid="awac123-F2" ref-type="fig">Fig. 2A and B</xref>). Precise subcellular
localization of TMEM63C was then performed by confocal microscopy in TMEM63C-FLAG
overexpressing HeLa cells counterstained for other cellular organelles. Co-localization
analysis showed that TMEM63C-FLAG specifically and solely localized to the ER, and not to
mitochondria, peroxisomes, lysosomes, endosomes, nor the Golgi apparatus (<xref rid="awac123-F2" ref-type="fig">Fig. 2C</xref>). The ER is not only the major cellular
storage for lipids and Ca<sup>2+</sup>, but also represents the cellular organelle that
establishes the largest number of physical contacts with other organelles at membrane
contact sites.<sup><xref rid="awac123-B5" ref-type="bibr">5</xref></sup> Among them, MERCs
have been the best characterized to date.<sup><xref rid="awac123-B5" ref-type="bibr">5</xref></sup> MERCs or MAMs represent functional signalling platforms where
specialized ER subdomains in close contact with the mitochondria control different
physiological functions like the trafficking of lipids and Ca<sup>2+</sup> required to
maintain cellular homeostasis.<sup><xref rid="awac123-B32" ref-type="bibr">32</xref></sup>
Interestingly, it has been recently highlighted that MERCs play a central role in multiple
neurodegenerative diseases, including HSP.<sup><xref rid="awac123-B33" ref-type="bibr">33</xref>,<xref rid="awac123-B34" ref-type="bibr">34</xref></sup> Thus, we
hypothesized that TMEM63C may localize at this interface. Subcellular fractionation
experiments were performed by differential centrifugation to isolate intracellular
compartments including heavy membranes, microsomes (containing ER), pure mitochondria and
MAM fractions. Notably, immunoblot analysis of these isolated fractions confirmed the
presence of TMEM63C in microsomes, but also identified an enrichment of TMEM63C in the
isolated MAM fraction, indicating a localization of the protein at this interface (<xref rid="awac123-F2" ref-type="fig">Fig. 2D</xref>). To confirm this, we performed
super-resolution N-structured illumination microscopy (N-SIM), which allow us to observe
not only the TMEM63C ER distribution (revealed by its co-localization with the ER marker
calnexin), but also the presence of TMEM63C-enriched ER subdomains in close contact with
the mitochondrial marker TOM20 (<xref rid="awac123-F2" ref-type="fig">Fig. 2E</xref> and
<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 2</xref>). Thus,
these data indicate that TMEM63C is an ER-localized protein, which is particularly
enriched at MERCs.</p>
        <fig position="float" id="awac123-F2" fig-type="figure">
          <label>Figure 2</label>
          <caption>
            <p>
<bold>TMEM63C distributes along the ER network and accumulates at MERCs.</bold>
(<bold>A</bold>) Representative confocal images of HeLa and SH-SY5Y cells
transfected with TMEM63C-Flag and labelled with an anti-Flag antibody. Nucleus were
labelled using DAPI. Scale bars&#x2009;=&#x2009;10&#x2005;&#xB5;m. (<bold>B</bold>) Immunoblot analysis showing
the efficiency of TMEM63C-Flag expression at 24&#x2005;h in both HeLa and SH-SY5Y cells.
VDAC1 and Tubulin were used as loading controls. (<bold>C</bold>) Representative
confocal images of HeLa cells transfected with TMEM63C-Flag showing TMEM63C-Flag
co-localization with the ER marker, Calnexin (<italic toggle="yes">top</italic>), compared to other
organelle markers (<italic toggle="yes">bottom</italic>). Mitochondria, peroxisomes, endosomes,
lysosomes and Golgi apparatus were labelled using anti-TOM20, anti-PMP70, anti-Rab7,
anti-LAMP1 and anti-p230 antibodies, respectively. Flag was labelled using an
anti-Flag antibody. On the <italic toggle="yes">right</italic>, 10&#x2005;&#xB5;m line-scan analyses of
relative fluorescence intensity from the dashed line are shown. Scale bars&#x2009;=&#x2009;10&#x2005;&#xB5;m.
(<bold>D</bold>) TMEM63C localization analysis by subcellular fractionation from
HeLa cells. Total cell lysates (whole cell) were fractionated into cytosolic
(cytosol), heavy crude mitochondria (HCM 2.3K), purified mitochondria (pure
mitochondria), MAMs and microsomal (microsomes) fractions. The following proteins were
used as compartment markers: VDAC1 for outer mitochondrial membrane and MAM, calnexin
for ER and MAM, ASCL4 and VAPB for MAM, PEX14 for peroxisomes and Tubulin for cytosol.
(<bold>E</bold>) Representative N-SIM super-resolution microscopy image of HeLa
cells expressing TMEM63C-Flag, showing TMEM63C-Flag <italic toggle="yes">foci</italic> accumulation
at MERCs (arrows). Flag, mitochondria and ER were labelled with anti-Flag, anti-TOM20
and anti-Calnexin antibodies, respectively. On the <italic toggle="yes">right</italic>, 2&#x2005;&#xB5;m
line-scan analyses of relative fluorescence intensity from the dashed line are shown.
Scale bars = 2&#x2005;&#xB5;m.</p>
          </caption>
          <graphic xlink:href="awac123f2" position="float"/>
        </fig>
        <p>Then, we evaluated how the absence of TMEM63C affects organelle homeostasis. To this
purpose, we first confirmed the endogenous expression and the efficiency of the
siRNA-mediated downregulation of <italic toggle="yes">TMEM63C</italic> gene by immunoblot analysis in
the different cell lines used in this study (HeLa, SH-SY5Y and NSC-34 cells) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3A</xref>). To
characterize the physiological relevance of TMEM63C at MERCs, potential abnormalities in
mitochondrial and ER dynamics were monitored in TMEM63C-deficient cells. The ER membranous
compartment consists of a nuclear envelope and a dynamic network of tubules. ER tubules
are densely packed in the juxtanuclear region forming ER sheets, required for protein
synthesis.<sup><xref rid="awac123-B35" ref-type="bibr">35</xref></sup> At the
periphery of the cell, the ER tubular conformation is less packed allowing the generation
of curved membranes, which generate ER-derived vesicles.<sup><xref rid="awac123-B35" ref-type="bibr">35</xref></sup> Therefore, maintaining a proper ratio between ER
sheets and tubules is essential for cellular viability. Indeed, multiple ER-shaping
proteins have been involved in HSP and the loss of HSP-associated molecules leads to the
expansion of ER sheets at the cell periphery.<sup><xref rid="awac123-B36" ref-type="bibr">36</xref></sup> Interestingly, silencing of <italic toggle="yes">TMEM63C</italic> in HeLa cells
disrupted the balance between sheets and tubules by increasing ER-sheet area (<xref rid="awac123-F3" ref-type="fig">Fig. 3A and B</xref>), suggesting that ER defects may
comprise a key pathomolecular aspect of TMEM63C-associated neurological disease.</p>
        <p>A number of ER-shaping or MERCs-localized proteins have been shown to control
mitochondrial functions, in particular regulating mitochondrial morphology.<sup><xref rid="awac123-B37" ref-type="bibr">37&#x2013;39</xref></sup>
Mitochondria are dynamic organelles constantly adapting their shape depending on the
cellular metabolic state by undergoing continuous cycles of fission and fusion
events.<sup><xref rid="awac123-B40" ref-type="bibr">40</xref></sup> The essential role
of MERCs in this process is well described, and altered mitochondrial shape has been
widely reported in multiple neurodegenerative conditions including HSP.<sup><xref rid="awac123-B41" ref-type="bibr">41&#x2013;45</xref></sup> Given the MERCs localization of TMEM63C, we thus monitored
mitochondrial morphology in cells silenced for <italic toggle="yes">TMEM63C</italic> in both HeLa
(<xref rid="awac123-F3" ref-type="fig">Fig. 3C&#x2013;E</xref>) and SH-SY5Y (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3B&#x2013;D</xref>) cells. This
led to a significant remodelling of the mitochondrial network characterized by an
increased number of cells harbouring elongated and interconnected mitochondria (<xref rid="awac123-F3" ref-type="fig">Fig. 3C and D</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3B and C</xref>), an
increase of the organelle area and size, and a decrease in mitochondrial number in the
region of interest (<xref rid="awac123-F3" ref-type="fig">Fig. 3E</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3D</xref>). Moreover,
loss of TMEM63C also induced mitochondrial branching, leading to a highly interconnected
network and an increase of mitochondrial intersections or junctions (<xref rid="awac123-F3" ref-type="fig">Fig. 3E</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3D</xref>), reinforcing
the elongated mitochondrial shape observed in TMEM63C-depleted cells. In addition, TMEM63C
gain of function analysis revealed opposite effects on mitochondrial morphology. Indeed,
TMEM63C overexpression leads to mitochondrial fragmentation characterized by an increased
number of cells harbouring small-round shaped mitochondria, as well as a decrease of
organelle area and size, accompanied by an increase in mitochondrial number in the region
of interest (<xref rid="awac123-F3" ref-type="fig">Fig. 3F&#x2013;H</xref>). This further
supports an important role of TMEM63C in regulating mitochondrial morphology at MERCs.
However, despite the altered mitochondrial morphology, mitochondrial respiration measured
by oxygraphy was not impaired in the absence of TMEM63C, although maximal respiration was
slightly decreased in <italic toggle="yes">TMEM63C</italic>-silenced SH-SY5Y cells after 6 days of
inhibition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig.
3E</xref>). Finally, we recapitulated the mitochondrial morphology phenotype in NSC-34
cells, a motor neuron-like cellular model usually used to investigate the
physiopathological mechanisms of motor neuron disease and therefore more relevant to
HSP.<sup><xref rid="awac123-B46" ref-type="bibr">46</xref></sup> To this end, we
differentiated and matured NSC-34 cells into motor neuron-like cells with several
morphological properties resembling those of motor neurons. As shown in <xref rid="awac123-F3" ref-type="fig">Fig. 3I</xref>, axons positive for the neuronal marker
Neurofilament H were selected and axonal mitochondrial morphology was analysed in the
presence or absence of TMEM63C. Quantification of the mitochondrial length (<xref rid="awac123-F3" ref-type="fig">Fig. 3I and J</xref>) revealed an increased
mitochondrial size in the axons of TMEM63C-deficient motor neuron-like cells, further
confirming a potential role of the protein in regulating mitochondrial morphology in the
nervous system.</p>
        <p>Together, these data indicate that TMEM63C localizes to ER and MERCs, where it is
important to maintain ER and mitochondrial morphologies and dynamics. It should be noted
that microscopy co-localization analysis using Mander&#x2019;s coefficient showed that loss of
TMEM63C did not lead to a decrease but rather a slight increase of MERCs, suggesting that
TMEM63C is not acting as a tether between ER and mitochondria but may have an important
role in regulating MERCs function and integrity (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. 3F</xref>). Given this, it may be hypothesized that
altered lipid and ion trafficking at MERCs may underlie the organelle morphology
abnormalities present in TMEM63C deficient cells.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="awac123-s4">
      <title>Discussion</title>
      <p>Here we present data from three unrelated families with HSP, providing compelling evidence
that biallelic loss of function sequence alterations in <italic toggle="yes">TMEM63C</italic> cause HSP.
All seven affected individuals presented in infancy with consistent clinical features of
lower-limb weakness and spasticity typical of HSP. Five additionally present with mild
intellectual impairment, which appears to represent a variable clinical outcome associated
with biallelic <italic toggle="yes">TMEM63C</italic> variants.</p>
      <p>So far, the function of TMEM63C has not been established, nor has it been shown to cause
human disease. Previous rat and zebrafish animal model studies of TMEM63C suggested a role
in kidney function. Schulz <italic toggle="yes">et al</italic>.<sup><xref rid="awac123-B47" ref-type="bibr">47</xref></sup> identified <italic toggle="yes">Tmem63c</italic> as a candidate due
to its position within the quantitative trait locus region in a strain of hypertensive rats
considered to be a suitable model system for investigating the genetic basis of albuminuria.
However, no sequence variants were identified in <italic toggle="yes">Tmem63c</italic> in hypertensive
rats,<sup><xref rid="awac123-B47" ref-type="bibr">47</xref>,<xref rid="awac123-B48" ref-type="bibr">48</xref></sup> and <italic toggle="yes">TMEM63C</italic> expression is absent in
human kidneys in the Genotype-Tissue Expression (GTEx) database. Here, we unequivocally
identify disruption of TMEM63C function as a cause of neurological disease in humans,
consistent with the high expression levels of the <italic toggle="yes">TMEM63</italic> family of
molecules in the nervous system.<sup><xref rid="awac123-B49" ref-type="bibr">49</xref></sup>
Further evidence for an important role for TMEM63 family of proteins in neurological
function is provided by the previous description of <italic toggle="yes">de novo</italic> heterozygous
pathogenic variants in TMEM63A associated with hypomyelinating leukodystrophy, which notably
comprises a spasticity component.<sup><xref rid="awac123-B50" ref-type="bibr">50</xref></sup> Consistent with this, <italic toggle="yes">Tmem63a</italic> knock out mice display
gait abnormalities, also indicative of neurological (and motor) impairment.<sup><xref rid="awac123-B50" ref-type="bibr">50</xref></sup> Similarly,
<italic toggle="yes">Tmem63b<sup>&#x2212;/&#x2212;</sup></italic> knock out is associated with an abnormal gait,
limb grasping and hyperactivity as well as preweaning lethality in mice.<sup><xref rid="awac123-B51" ref-type="bibr">51</xref>,<xref rid="awac123-B52" ref-type="bibr">52</xref></sup> Du <italic toggle="yes">et al</italic>.<sup><xref rid="awac123-B31" ref-type="bibr">31</xref></sup> also identified a possible role of TMEM63B in hearing by studying
<italic toggle="yes">Tmem63b</italic><sup>&#x2212;/&#x2212;</sup> mice, found to be insensitive to sound stimuli due
to severe degeneration of outer hair cells.</p>
      <p>To better understand the functional role of TMEM63C, we performed <italic toggle="yes">in
cellula</italic> studies to monitor protein subcellular localization, and the impact on
both ER and mitochondrial morphologies in two different mammalian cell lines. First, we
showed by microscopy analysis that TMEM63C is exclusively localized at the ER, evidenced by
its reticular distribution and co-localization with the <italic toggle="yes">bona fide</italic> ER
marker, calnexin. In particular, both biochemical and super-resolution microscopy analyses
revealed an accumulation of TMEM63C at MERCs. Consistent with a role at MERCs,
<italic toggle="yes">TMEM63C</italic> silencing in both HeLa and SH-SY5Y cells resulted in ER and
mitochondrial morphological changes primarily characterized by an increase of the balance
between ER sheets and tubules, and by mitochondrial elongation and interconnectivity.
Mitochondrial hyperfusion is induced by a disruption of the mitochondrial fission&#x2013;fusion
balance and has been identified as a mechanism of defence on cellular stress to enhance cell
survival.<sup><xref rid="awac123-B39" ref-type="bibr">39</xref></sup> The importance of
mitochondrial dynamics (including fission, fusion and transport) has been extensively
documented to be of critical importance in neuronal development and survival, and
alterations in these dynamics are known to contribute to the pathology of several diseases,
including neurological disorders.<sup><xref rid="awac123-B53" ref-type="bibr">53</xref></sup> Although HeLa (derived from cervical cancer cells) and SH-SY5Y
(neuroblastoma) cells are well established models for molecular and cell biology studies and
provide initial insight into the potential function of TMEM63C at MERCs, both cell lines may
be of limited relevance to the study of neuronal physiology in HSP. Therefore, we sought to
confirm our findings in more physiologically relevant differentiated and maturated motor
neuron-like NSC-34 cells. This again showed that TMEM63C loss leads to a defective
mitochondrial morphology network, further emphasizing that altered mitochondrial dynamics
potentially underlie the pathological manifestations observed in HSP patients. In this
context, as our data suggest that global mitochondrial respiration is not grossly affected,
we hypothesize that the mitochondrial elongation observed in TMEM63C-deficient cells may
affect organelle motility through the axon resulting in neuronal bioenergetic defects when a
specific or rapid production of ATP is required at specific cellular subdomains.<sup><xref rid="awac123-B54" ref-type="bibr">54</xref></sup> Moreover, enlargement of mitochondria
may negatively affect the respiration capacity and result in mitochondria that are more
resistant to selective degradation by mitophagy.<sup><xref rid="awac123-B55" ref-type="bibr">55</xref></sup> This autophagic degradation defect may impair the proper turnover of
the organelle, leading to the accumulation of damaged and dysfunctional mitochondria, which
may contribute to axonal degeneration.<sup><xref rid="awac123-B56" ref-type="bibr">56</xref></sup> Similarly, it has been suggested that the increased ratio of ER sheet to
tubules may underlie the partial loss of the organelle in the distal motor axons, as
described with receptor accessory protein 1 (<italic toggle="yes">REEP1</italic>) gene variants
associated with HSP.<sup><xref rid="awac123-B36" ref-type="bibr">36</xref></sup> Indeed, the
reduction of ER membranes in distal axons may not only affect the lipid composition of the
different neuronal membranes and decrease membrane contact sites between the ER and other
organelles, but also alter the local generation and propagation of Ca<sup>2+</sup> fluxes
that is critically important for axon function.<sup><xref rid="awac123-B57" ref-type="bibr">57</xref></sup></p>
      <p>Together, these data support an important role for TMEM63C in maintaining ER-mitochondrial
organelle homeostasis and structure, likely to underlie HSP pathological outcomes.
Maintained MERCs integrity is known to be of critical importance for a number of subcellular
processes crucial for neuronal health, including lipid and calcium homeostasis.<sup><xref rid="awac123-B58" ref-type="bibr">58</xref></sup> Our data show that
<italic toggle="yes">TMEM63C</italic> silencing alters organelle integrity of both mitochondria and ER,
reflecting a potential role for this protein in the maintenance of these structures. Notably
there is increasing evidence linking the role of HSP-associated genes with lipid
homeostasis, including oxysterol-cholesterol and phosphatidylethanolamine metabolic
pathways,<sup><xref rid="awac123-B2" ref-type="bibr">2</xref>,<xref rid="awac123-B59" ref-type="bibr">59</xref></sup> mediated in part through MERCs.<sup><xref rid="awac123-B2" ref-type="bibr">2</xref></sup> The molecular role of TMEM63C proposed
here is thus consistent with a potential role in lipid (and other) metabolic processes
mediated through MERCs, and in the regulation of organelle morphology and cellular
homeostasis. Further work is required to understand the precise cellular role of TMEM63C,
and the specific pathomolecular outcomes associated with pathogenic <italic toggle="yes">TMEM63C</italic>
variants. One limitation of the current study has been that we have been unable to obtain
patient-derived fibroblasts to investigate the effects of <italic toggle="yes">TMEM63C</italic> gene
variants in the most appropriate cellular models. Indeed, while our data show clear parity
across a range of cell lines including differentiated and maturated motor neuron-like NSC-34
cells, they fail to completely mimic the selective neuronal vulnerability observed in HSP
and therefore fully reveal the neuropathological basis of disease in patients. In future, it
will be valuable to perform similar studies in active motor neurons reprogrammed from
patient-derived fibroblasts using induced-pluripotent stem cell (iPSC) technology, to
corroborate the role of TMEM63C in maintaining organelle morphology, but also to more fully
reveal the HSP neuro-pathomechanism. Such endeavours will further increase our understanding
of how deficits in ER&#x2014;mitochondrial connectivity and function may lead to motor neuron
degenerative disease, paving the way for targeted therapeutics.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material id="sup1" position="float" content-type="local-data">
        <label>awac123_Supplementary_Data</label>
        <media xlink:href="awac123_supplementary_data.zip">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="ack1">
      <title>Acknowledgements</title>
      <p>The authors would like to thank the affected individuals and their family members for their
participation in this study, and Hereditary Spastic Paraplegia Support Group for their wider
support of our work.</p>
    </ack>
    <sec id="awac123-s5">
      <title>Funding</title>
      <p>The authors are grateful for funding support provided by the Halpin Trust, Hereditary
Spastic Paraplegia Support Group, Medical Research Council UK (MRC; MC_UU_00015/7 to J.P.,
G1002279 to A.H.C. and G1001931 to E.L.B., MC-PC-18047, MC_PC_15054, MC_PC_15047 to
University of Exeter, E.L.B. and A.H.C.), Newlife Foundation for Disabled Children (A.H.C.
and E.L.B.), and the Oman Ministry of Higher Education, Sultanate of Oman (to F.A.S., A.A.
and A.H.C.). L.C.T. is recipient of a Ramon Areces postdoctoral fellowship. M.P. is a
MRC-funded PhD student.</p>
    </sec>
    <sec id="awac123-s6">
      <title>Competing interests</title>
      <p>The authors report no competing interests.</p>
    </sec>
    <sec id="awac123-s7">
      <title>Supplementary material</title>
      <p>
<xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is
available at <italic toggle="yes">Brain</italic> online.</p>
    </sec>
    <ref-list id="ref1">
      <title>References</title>
      <ref id="awac123-B1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shribman</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Reid</surname><given-names>E</given-names></string-name>, <string-name><surname>Crosby</surname><given-names>AH</given-names></string-name>, <string-name><surname>Houlden</surname><given-names>H</given-names></string-name>, <string-name><surname>Warner</surname><given-names>TT</given-names></string-name></person-group>.
<article-title>Hereditary spastic paraplegia: From diagnosis to emerging therapeutic
approaches</article-title>. <source>Lancet Neurol</source>.
<year>2019</year>;<volume>18</volume>:<fpage>1136</fpage>&#x2013;<lpage>1146</lpage>.<pub-id pub-id-type="pmid">31377012</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rickman</surname>
<given-names>OJ</given-names>
</string-name>, <string-name><surname>Baple</surname><given-names>EL</given-names></string-name>, <string-name><surname>Crosby</surname><given-names>AH</given-names></string-name></person-group>.
<article-title>Lipid metabolic pathways converge in motor neuron degenerative
diseases</article-title>. <source>Brain</source>.
<year>2020</year>;<volume>143</volume>:<fpage>1073</fpage>&#x2013;<lpage>1087</lpage>.<pub-id pub-id-type="pmid">31848577</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bellofatto</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>De
Michele</surname><given-names>G</given-names></string-name>, <string-name><surname>Iovino</surname><given-names>A</given-names></string-name>, <string-name><surname>Filla</surname><given-names>A</given-names></string-name>, <string-name><surname>Santorelli</surname><given-names>FM</given-names></string-name></person-group>.
<article-title>Management of hereditary spastic paraplegia: A systematic review of the
literature</article-title>. <source>Front Neurol</source>.
<year>2019</year>;<volume>10</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">30723448</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Giudice T</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Lombardi</surname><given-names>F</given-names></string-name>, <string-name><surname>Santorelli</surname><given-names>FM</given-names></string-name>,
<string-name><surname>Kawarai</surname><given-names>T</given-names></string-name>, <string-name><surname>Orlacchio</surname><given-names>A</given-names></string-name></person-group>.
<article-title>Hereditary spastic paraplegia: clinical-genetic characteristics and
evolving molecular mechanisms</article-title>. <source>Exp Neurol</source>.
<year>2014</year>;<volume>261</volume>:<fpage>518</fpage>&#x2013;<lpage>539</lpage>.<pub-id pub-id-type="pmid">24954637</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Phillips</surname>
<given-names>MJ</given-names>
</string-name>, <string-name><surname>Voeltz</surname><given-names>GK</given-names></string-name></person-group>.
<article-title>Structure and function of ER membrane contact sites with other
organelles</article-title>. <source>Nat Rev Mol Cell Biol</source>.
<year>2016</year>;<volume>17</volume>:<fpage>69</fpage>&#x2013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">26627931</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Csordas</surname>
<given-names>G</given-names>
</string-name>, <string-name><surname>Weaver</surname><given-names>D</given-names></string-name>, <string-name><surname>Hajnoczky</surname><given-names>G</given-names></string-name></person-group>.
<article-title>Endoplasmic reticulum-mitochondrial contactology: Structure and signaling
functions</article-title>. <source>Trends Cell Biol</source>.
<year>2018</year>;<volume>28</volume>:<fpage>523</fpage>&#x2013;<lpage>540</lpage>.<pub-id pub-id-type="pmid">29588129</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Scorrano</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>De
Matteis</surname><given-names>MA</given-names></string-name>, <string-name><surname>Emr</surname><given-names>S</given-names></string-name>,
<etal>et al</etal></person-group>
<article-title>Coming together to define membrane contact sites</article-title>.
<source>Nat Commun</source>.
<year>2019</year>;<volume>10</volume>:<fpage>1287</fpage>.<pub-id pub-id-type="pmid">30894536</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blom</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Somerharju</surname><given-names>P</given-names></string-name>,
<string-name><surname>Ikonen</surname><given-names>E</given-names></string-name></person-group>.
<article-title>Synthesis and biosynthetic trafficking of membrane
lipids</article-title>. <source>Cold Spring Harb Perspect Biol</source>.
<year>2011</year>;<volume>3</volume>:<fpage>a004713</fpage>.<pub-id pub-id-type="pmid">21482741</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tatsuta</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Scharwey</surname><given-names>M</given-names></string-name>, <string-name><surname>Langer</surname><given-names>T</given-names></string-name></person-group>.
<article-title>Mitochondrial lipid trafficking</article-title>. <source>Trends Cell
Biol</source>.
<year>2014</year>;<volume>24</volume>:<fpage>44</fpage>&#x2013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">24001776</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Flis</surname>
<given-names>VV</given-names>
</string-name>, <string-name><surname>Daum</surname><given-names>G</given-names></string-name></person-group>.
<article-title>Lipid transport between the endoplasmic reticulum and
mitochondria</article-title>. <source>Cold Spring Harb Perspect Biol</source>.
<year>2013</year>;<volume>5</volume>:<fpage>a013235</fpage>.<pub-id pub-id-type="pmid">23732475</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ahmed</surname>
<given-names>MY</given-names>
</string-name>, <string-name><surname>Al-Khayat</surname><given-names>A</given-names></string-name>,
<string-name><surname>Al-Murshedi</surname><given-names>F</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>A mutation of EPT1 (SELENOI) underlies a new disorder of Kennedy pathway
phospholipid biosynthesis</article-title>. <source>Brain</source>.
<year>2017</year>;<volume>140</volume>:<fpage>547</fpage>&#x2013;<lpage>554</lpage>.<pub-id pub-id-type="pmid">28052917</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vaz</surname>
<given-names>FM</given-names>
</string-name>, <string-name><surname>McDermott</surname><given-names>JH</given-names></string-name>,
<string-name><surname>Alders</surname><given-names>M</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex
hereditary spastic paraplegia</article-title>. <source>Brain</source>.
<year>2019</year>;<volume>142</volume>:<fpage>3382</fpage>&#x2013;<lpage>3397</lpage>.<pub-id pub-id-type="pmid">31637422</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Muallem</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Chung</surname><given-names>WY</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A</given-names></string-name>,
<string-name><surname>Ahuja</surname><given-names>M</given-names></string-name></person-group>.
<article-title>Lipids at membrane contact sites: cell signaling and ion
transport</article-title>. <source>EMBO Rep</source>.
<year>2017</year>;<volume>18</volume>:<fpage>1893</fpage>&#x2013;<lpage>1904</lpage>.<pub-id pub-id-type="pmid">29030479</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vance</surname>
<given-names>JE</given-names>
</string-name>
</person-group>. <article-title>MAM (mitochondria-associated membranes) in mammalian
cells: Lipids and beyond</article-title>. <source>Biochim Biophys Acta</source>.
<year>2014</year>;<volume>1841</volume>:<fpage>595</fpage>&#x2013;<lpage>609</lpage>.<pub-id pub-id-type="pmid">24316057</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Murthy</surname>
<given-names>SE</given-names>
</string-name>, <string-name><surname>Dubin</surname><given-names>AE</given-names></string-name>, <string-name><surname>Whitwam</surname><given-names>T</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>OSCA/TMEM63 are an evolutionarily conserved family of mechanically
activated ion channels</article-title>. <source>eLife</source>.
<year>2018</year>;<volume>7</volume>:<fpage>e41844</fpage>.<pub-id pub-id-type="pmid">30382938</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhao</surname>
<given-names>X</given-names>
</string-name>, <string-name><surname>Yan</surname><given-names>X</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>,
<string-name><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name><surname>Ni</surname><given-names>X</given-names></string-name></person-group>.
<article-title>Co-expression of mouse TMEM63A. TME:M63B. and TMEM63C confers
hyperosmolarity activated ion currents in HEK293 cells</article-title>. <source>Cell
Biochem Funct</source>.
<year>2016</year>;<volume>34</volume>:<fpage>238</fpage>&#x2013;<lpage>241</lpage>.<pub-id pub-id-type="pmid">27045885</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hussy</surname>
<given-names>N</given-names>
</string-name>, <string-name><surname>Deleuze</surname><given-names>C</given-names></string-name>, <string-name><surname>Desarmenien</surname><given-names>MG</given-names></string-name>,
<string-name><surname>Moos</surname><given-names>FC</given-names></string-name></person-group>.
<article-title>Osmotic regulation of neuronal activity: A new role for taurine and glial
cells in a hypothalamic neuroendocrine structure</article-title>. <source>Prog
Neurobiol</source>.
<year>2000</year>;<volume>62</volume>:<fpage>113</fpage>&#x2013;<lpage>134</lpage>.<pub-id pub-id-type="pmid">10828380</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jojoa-Cruz</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Saotome</surname><given-names>K</given-names></string-name>, <string-name><surname>Murthy</surname><given-names>SE</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Cryo-EM structure of the mechanically activated ion channel
OSCA1.2</article-title>. <source>eLife</source>.
<year>2018</year>;<volume>7</volume>:<fpage>e41845</fpage>.<pub-id pub-id-type="pmid">30382939</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Wang</surname><given-names>D</given-names></string-name>, <string-name><surname>Kang</surname><given-names>Y</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Structure of the mechanosensitive OSCA channels</article-title>.
<source>Nat Struct Mol Biol</source>.
<year>2018</year>;<volume>25</volume>:<fpage>850</fpage>&#x2013;<lpage>858</lpage>.<pub-id pub-id-type="pmid">30190597</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Benarroch</surname>
<given-names>EE</given-names>
</string-name>
</person-group>. <article-title>Anoctamins (TMEM16 proteins): Functions and involvement in
neurologic disease</article-title>. <source>Neurology</source>.
<year>2017</year>;<volume>89</volume>:<fpage>722</fpage>&#x2013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">28724583</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Petkovic</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Oses-Prieto</surname><given-names>J</given-names></string-name>,
<string-name><surname>Burlingame</surname><given-names>A</given-names></string-name>,
<string-name><surname>Jan</surname><given-names>LY</given-names></string-name>, <string-name><surname>Jan</surname><given-names>YN</given-names></string-name></person-group>.
<article-title>TMEM16K is an interorganelle regulator of endosomal
sorting</article-title>. <source>Nat Commun</source>.
<year>2020</year>;<volume>11</volume>:<fpage>3298</fpage>.<pub-id pub-id-type="pmid">32620747</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B22">
        <label>22</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zaman</surname>
<given-names>MF</given-names>
</string-name>, <string-name><surname>Nenadic</surname><given-names>A</given-names></string-name>, <string-name><surname>Radoji&#x10D;i&#x107;</surname><given-names>A</given-names></string-name>, <string-name><surname>Rosado</surname><given-names>A</given-names></string-name>, <string-name><surname>Beh</surname><given-names>CT</given-names></string-name></person-group>.
<article-title>Sticking with it: ER-PM membrane contact sites as a coordinating nexus
for regulating lipids and proteins at the cell cortex</article-title>. <source>Front
Cell Dev Biol</source>.
<year>2020</year>;<volume>8</volume>:<fpage>675</fpage>.<pub-id pub-id-type="pmid">32793605</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B23">
        <label>23</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vona</surname>
<given-names>B</given-names>
</string-name>, <string-name><surname>Mazaheri</surname><given-names>N</given-names></string-name>, <string-name><surname>Lin</surname><given-names>SJ</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>A biallelic variant in CLRN2 causes non-syndromic hearing loss in
humans</article-title>. <source>Hum Genet</source>.
<year>2021</year>;<volume>140</volume>:<fpage>915</fpage>&#x2013;<lpage>931</lpage>.<pub-id pub-id-type="pmid">33496845</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B24">
        <label>24</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hounoum B</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Vourc'h</surname><given-names>P</given-names></string-name>, <string-name><surname>Felix</surname><given-names>R</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>NSC-34 motor neuron-like cells are unsuitable as experimental model for
glutamate-mediated excitotoxicity</article-title>. <source>Front Cell Neurosci</source>.
<year>2016</year>;<volume>10</volume>:<fpage>118</fpage>.<pub-id pub-id-type="pmid">27242431</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B25">
        <label>25</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Prudent</surname>
<given-names>J</given-names>
</string-name>, <string-name><surname>Zunino</surname><given-names>R</given-names></string-name>, <string-name><surname>Sugiura</surname><given-names>A</given-names></string-name>, <string-name><surname>Mattie</surname><given-names>S</given-names></string-name>, <string-name><surname>Shore</surname><given-names>GC</given-names></string-name>, <string-name><surname>McBride</surname><given-names>HM</given-names></string-name></person-group>.
<article-title>MAPL SUMOylation of Drp1 stabilizes an ER/Mitochondrial platform required
for cell death</article-title>. <source>Mol Cell</source>.
<year>2015</year>;<volume>59</volume>:<fpage>941</fpage>&#x2013;<lpage>955</lpage>.<pub-id pub-id-type="pmid">26384664</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B26">
        <label>26</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nagashima</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Tabara</surname><given-names>LC</given-names></string-name>, <string-name><surname>Tilokani</surname><given-names>L</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Golgi-derived PI(4)P-containing vesicles drive late steps of mitochondrial
division</article-title>. <source>Science</source>.
<year>2020</year>;<volume>367</volume>:<fpage>1366</fpage>&#x2013;<lpage>1371</lpage>.<pub-id pub-id-type="pmid">32193326</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B27">
        <label>27</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Lanjuin</surname><given-names>A</given-names></string-name>, <string-name><surname>Chowdhury</surname><given-names>SR</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Neuronal TORC1 modulates longevity via AMPK and cell nonautonomous
regulation of mitochondrial dynamics in <italic toggle="yes">C. elegans</italic></article-title>.
<source>eLife</source>.
<year>2019</year>;<volume>8</volume>:<fpage>e49158</fpage>.<pub-id pub-id-type="pmid">31411562</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B28">
        <label>28</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pesta</surname>
<given-names>D</given-names>
</string-name>, <string-name><surname>Gnaiger</surname><given-names>E</given-names></string-name></person-group>.
<article-title>High-resolution respirometry: OXPHOS protocols for human cells and
permeabilized fibers from small biopsies of human muscle.</article-title><source>Methods
Mol Biol</source>.
<year>2012</year>;<volume>810</volume>:<fpage>25</fpage>&#x2013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">22057559</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B29">
        <label>29</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Williamson</surname>
<given-names>CD</given-names>
</string-name>, <string-name><surname>Wong</surname><given-names>DS</given-names></string-name>, <string-name><surname>Bozidis</surname><given-names>P</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>A</given-names></string-name>, <string-name><surname>Colberg-Poley</surname><given-names>AM</given-names></string-name></person-group>.
<article-title>Isolation of endoplasmic reticulum. Mitochondria, and
mitochondria-associated membrane and detergent resistant membrane fractions from
transfected cells and from human cytomegalovirus-infected primary
fibroblasts</article-title>. <source>Curr Protoc Cell Biol</source>.
<year>2015</year>;<volume>68</volume>:<fpage>3.27.1</fpage>&#x2013;<lpage>3.27.33</lpage>.<pub-id pub-id-type="pmid">26331984</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B30">
        <label>30</label>
        <mixed-citation publication-type="other">
<comment>
<italic toggle="yes">LMSgrowth</italic>. Version 2.77. Harlow Healthcare</comment>. <date-in-citation content-type="access">Accessed 10 June 2021</date-in-citation>. <ext-link xlink:href="https://www.healthforallchildren.com/lmsgrowth-download/" ext-link-type="uri">https://www.healthforallchildren.com/lmsgrowth-download/</ext-link></mixed-citation>
      </ref>
      <ref id="awac123-B31">
        <label>31</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Du</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Ye</surname><given-names>C</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D</given-names></string-name>,
<etal>et al</etal></person-group>
<article-title>The cation channel TMEM63B Is an osmosensor required for
hearing</article-title>. <source>Cell Rep</source>.
<year>2020</year>;<volume>31</volume>:<fpage>107596</fpage>.<pub-id pub-id-type="pmid">32375046</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B32">
        <label>32</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Prinz</surname>
<given-names>WA</given-names>
</string-name>, <string-name><surname>Toulmay</surname><given-names>A</given-names></string-name>, <string-name><surname>Balla</surname><given-names>T</given-names></string-name></person-group>.
<article-title>The functional universe of membrane contact sites</article-title>.
<source>Nat Rev Mol Cell Biol</source>.
<year>2020</year>;<volume>21</volume>:<fpage>7</fpage>&#x2013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">31732717</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B33">
        <label>33</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fowler</surname>
<given-names>PC</given-names>
</string-name>, <string-name><surname>Garcia-Pardo</surname><given-names>ME</given-names></string-name>,
<string-name><surname>Simpson</surname><given-names>JC</given-names></string-name>, <string-name><surname>O&#x2019;Sullivan</surname><given-names>NC</given-names></string-name></person-group>.
<article-title>NeurodegenERation: The central role for ER contacts in neuronal function
and axonopathy, lessons from hereditary spastic paraplegias and related
diseases</article-title>. <source>Front Neurosci</source>.
<year>2019</year>;<volume>13</volume>:<fpage>1051</fpage>.<pub-id pub-id-type="pmid">31680803</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B34">
        <label>34</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Krols</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>van
Isterdael</surname><given-names>G</given-names></string-name>, <string-name><surname>Asselbergh</surname><given-names>B</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Mitochondria-associated membranes as hubs for
neurodegeneration</article-title>. <source>Acta Neuropathol</source>.
<year>2016</year>;<volume>131</volume>:<fpage>505</fpage>&#x2013;<lpage>523</lpage>.<pub-id pub-id-type="pmid">26744348</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B35">
        <label>35</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schwarz</surname>
<given-names>DS</given-names>
</string-name>, <string-name><surname>Blower</surname><given-names>MD</given-names></string-name></person-group>.
<article-title>The endoplasmic reticulum: Structure, function and response to cellular
signaling</article-title>. <source>Cell Mol Life Sci</source>.
<year>2016</year>;<volume>73</volume>:<fpage>79</fpage>&#x2013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">26433683</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B36">
        <label>36</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yal&#xE7;&#x131;n</surname>
<given-names>B</given-names>
</string-name>, <string-name><surname>Zhao</surname><given-names>L</given-names></string-name>, <string-name><surname>Stofanko</surname><given-names>M</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Modeling of axonal endoplasmic reticulum network by spastic paraplegia
proteins</article-title>. <source>eLife</source>.
<year>2017</year>;<volume>6</volume>:<fpage>e23882</fpage>.<pub-id pub-id-type="pmid">28742022</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B37">
        <label>37</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Abrisch</surname>
<given-names>RG</given-names>
</string-name>, <string-name><surname>Gumbin</surname><given-names>SC</given-names></string-name>, <string-name><surname>Wisniewski</surname><given-names>BT</given-names></string-name>,
<string-name><surname>Lackner</surname><given-names>LL</given-names></string-name>, <string-name><surname>Voeltz</surname><given-names>GK</given-names></string-name></person-group>.
<article-title>Fission and fusion machineries converge at ER contact sites to regulate
mitochondrial morphology</article-title>. <source>J Cell Biol</source>.
<year>2020</year>;<volume>219</volume>:<fpage>201911122</fpage>.</mixed-citation>
      </ref>
      <ref id="awac123-B38">
        <label>38</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fowler</surname>
<given-names>PC</given-names>
</string-name>, <string-name><surname>O&#x2019;Sullivan</surname><given-names>NC</given-names></string-name></person-group>.
<article-title>ER-shaping proteins are required for ER and mitochondrial network
organization in motor neurons</article-title>. <source>Hum Mol Genet</source>.
<year>2016</year>;<volume>25</volume>:<fpage>2827</fpage>&#x2013;<lpage>2837</lpage>.<pub-id pub-id-type="pmid">27170313</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B39">
        <label>39</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>T&#xE1;bara</surname>
<given-names>LC</given-names>
</string-name>, <string-name><surname>Morris</surname><given-names>JL</given-names></string-name>, <string-name><surname>Prudent</surname><given-names>J</given-names></string-name></person-group>.
<article-title>The complex dance of organelles during mitochondrial
division</article-title>. <source>Trends Cell Biol</source>.
<year>2021</year>;<volume>31</volume>:<fpage>241</fpage>&#x2013;<lpage>253</lpage>.<pub-id pub-id-type="pmid">33446409</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B40">
        <label>40</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tilokani</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Nagashima</surname><given-names>S</given-names></string-name>,
<string-name><surname>Paupe</surname><given-names>V</given-names></string-name>, <string-name><surname>Prudent</surname><given-names>J</given-names></string-name></person-group>.
<article-title>Mitochondrial dynamics: Overview of molecular mechanisms</article-title>.
<source>Essays Biochem</source>.
<year>2018</year>;<volume>62</volume>:<fpage>341</fpage>&#x2013;<lpage>360</lpage>.<pub-id pub-id-type="pmid">30030364</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B41">
        <label>41</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cooper</surname>
<given-names>HM</given-names>
</string-name>, <string-name><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ylikallio</surname><given-names>E</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs
mitochondrial dynamics in dominant hereditary spastic paraplegia</article-title>.
<source>Hum Mol Genet</source>.
<year>2017</year>;<volume>26</volume>:<fpage>1432</fpage>&#x2013;<lpage>1443</lpage>.<pub-id pub-id-type="pmid">28158749</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B42">
        <label>42</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Denton</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Mou</surname><given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname><given-names>CC</given-names></string-name>,
<etal>et al</etal></person-group>
<article-title>Impaired mitochondrial dynamics underlie axonal defects in hereditary
spastic paraplegias</article-title>. <source>Hum Mol Genet</source>.
<year>2018</year>;<volume>27</volume>:<fpage>2517</fpage>&#x2013;<lpage>2530</lpage>.<pub-id pub-id-type="pmid">29726929</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B43">
        <label>43</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lavie</surname>
<given-names>J</given-names>
</string-name>, <string-name><surname>Serrat</surname><given-names>R</given-names></string-name>, <string-name><surname>Bellance</surname><given-names>N</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Mitochondrial morphology and cellular distribution are altered in SPG31
patients and are linked to DRP1 hyperphosphorylation</article-title>. <source>Hum Mol
Genet</source>.
<year>2017</year>;<volume>26</volume>:<fpage>674</fpage>&#x2013;<lpage>685</lpage>.<pub-id pub-id-type="pmid">28007911</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B44">
        <label>44</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lim</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Cho</surname><given-names>IT</given-names></string-name>, <string-name><surname>Schoel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Cho</surname><given-names>G</given-names></string-name>,
<string-name><surname>Golden</surname><given-names>JA</given-names></string-name></person-group>.
<article-title>Hereditary spastic paraplegia-linked REEP1 modulates endoplasmic
reticulum/mitochondria contacts</article-title>. <source>Ann Neurol</source>.
<year>2015</year>;<volume>78</volume>:<fpage>679</fpage>&#x2013;<lpage>696</lpage>.<pub-id pub-id-type="pmid">26201691</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B45">
        <label>45</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Magri</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Fracasso</surname><given-names>V</given-names></string-name>, <string-name><surname>Plumari</surname><given-names>M</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism
and optic atrophy with aberrant OPA1 processing and mitochondrial network
fragmentation</article-title>. <source>Hum Mutat</source>.
<year>2018</year>;<volume>39</volume>:<fpage>2060</fpage>&#x2013;<lpage>2071</lpage>.<pub-id pub-id-type="pmid">30252181</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B46">
        <label>46</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cashman</surname>
<given-names>NR</given-names>
</string-name>, <string-name><surname>Durham</surname><given-names>HD</given-names></string-name>, <string-name><surname>Blusztajn</surname><given-names>JK</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing
motor neurons</article-title>. <source>Dev Dyn</source>.
<year>1992</year>;<volume>194</volume>:<fpage>209</fpage>&#x2013;<lpage>221</lpage>.<pub-id pub-id-type="pmid">1467557</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B47">
        <label>47</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schulz</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Muller</surname><given-names>NV</given-names></string-name>, <string-name><surname>van de
Lest</surname><given-names>NA</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Analysis of the genomic architecture of a complex trait locus in
hypertensive rat models links Tmem63c to kidney damage</article-title>.
<source>eLife</source>.
<year>2019</year>;<volume>8</volume>:<fpage>e42068</fpage>.<pub-id pub-id-type="pmid">30900988</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B48">
        <label>48</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Eisenreich</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Orphal</surname><given-names>M</given-names></string-name>, <string-name><surname>Bohme</surname><given-names>K</given-names></string-name>, <string-name><surname>Kreutz</surname><given-names>R</given-names></string-name></person-group>.
<article-title>Tmem63c is a potential pro-survival factor in angiotensin II-treated
human podocytes</article-title>. <source>Life Sci</source>.
<year>2020</year>;<volume>258</volume>:<fpage>118175</fpage>.<pub-id pub-id-type="pmid">32750436</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B49">
        <label>49</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Aref-Eshghi</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Rodenhiser</surname><given-names>DI</given-names></string-name>,
<string-name><surname>Schenkel</surname><given-names>LC</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Genomic DNA methylation signatures enable concurrent diagnosis and clinical
genetic variant classification in neurodevelopmental syndromes</article-title>.
<source>Am J Hum Genet</source>.
<year>2018</year>;<volume>102</volume>:<fpage>156</fpage>&#x2013;<lpage>174</lpage>.<pub-id pub-id-type="pmid">29304373</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B50">
        <label>50</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yan</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Helman</surname><given-names>G</given-names></string-name>, <string-name><surname>Murthy</surname><given-names>SE</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Heterozygous variants in the mechanosensitive ion channel TMEM63A result in
transient hypomyelination during infancy</article-title>. <source>Am J Hum
Genet</source>.
<year>2019</year>;<volume>105</volume>:<fpage>996</fpage>&#x2013;<lpage>1004</lpage>.<pub-id pub-id-type="pmid">31587869</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B51">
        <label>51</label>
        <mixed-citation publication-type="other">International mouse phenotyping consortium.
Accessed 5 May 2022. <ext-link xlink:href="https://www.mousephenotype.org/" ext-link-type="uri">https://www.mousephenotype.org/</ext-link></mixed-citation>
      </ref>
      <ref id="awac123-B52">
        <label>52</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dickinson</surname>
<given-names>ME</given-names>
</string-name>, <string-name><surname>Flenniken</surname><given-names>AM</given-names></string-name>,
<string-name><surname>Ji</surname><given-names>X</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>High-throughput discovery of novel developmental
phenotypes</article-title>. <source>Nature</source>.
<year>2016</year>;<volume>537</volume>:<fpage>508</fpage>&#x2013;<lpage>514</lpage>.<pub-id pub-id-type="pmid">27626380</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B53">
        <label>53</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Flippo</surname>
<given-names>KH</given-names>
</string-name>, <string-name><surname>Strack</surname><given-names>S</given-names></string-name></person-group>.
<article-title>Mitochondrial dynamics in neuronal injury, development and
plasticity</article-title>. <source>J Cell Sci</source>.
<year>2017</year>;<volume>130</volume>:<fpage>671</fpage>&#x2013;<lpage>681</lpage>.<pub-id pub-id-type="pmid">28154157</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B54">
        <label>54</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mandal</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Drerup</surname><given-names>CM</given-names></string-name></person-group>.
<article-title>Axonal transport and mitochondrial function in neurons</article-title>.
<source>Front Cell Neurosci</source>.
<year>2019</year>;<volume>13</volume>:<fpage>373</fpage>.<pub-id pub-id-type="pmid">31447650</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B55">
        <label>55</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gomes</surname>
<given-names>LC</given-names>
</string-name>, <string-name><surname>Scorrano</surname><given-names>L</given-names></string-name></person-group>.
<article-title>Mitochondrial morphology in mitophagy and macroautophagy</article-title>.
<source>Biochim Biophys Acta</source>.
<year>2013</year>;<volume>1833</volume>:<fpage>205</fpage>&#x2013;<lpage>212</lpage>.<pub-id pub-id-type="pmid">22406072</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B56">
        <label>56</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mou</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>XJ</given-names></string-name></person-group>.
<article-title>Rescue axonal defects by targeting mitochondrial dynamics in hereditary
spastic paraplegias</article-title>. <source>Neural Regen Res</source>.
<year>2019</year>;<volume>14</volume>:<fpage>574</fpage>&#x2013;<lpage>577</lpage>.<pub-id pub-id-type="pmid">30632492</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B57">
        <label>57</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ross</surname>
<given-names>WN</given-names>
</string-name>
</person-group>. <article-title>Understanding calcium waves and sparks in central
neurons</article-title>. <source>Nat Rev Neurosci</source>.
<year>2012</year>;<volume>13</volume>:<fpage>157</fpage>&#x2013;<lpage>168</lpage>.<pub-id pub-id-type="pmid">22314443</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B58">
        <label>58</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Veeresh</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Kaur</surname><given-names>H</given-names></string-name>, <string-name><surname>Sarmah</surname><given-names>D</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Endoplasmic reticulum-mitochondria crosstalk: from junction to function
across neurological disorders</article-title>. <source>Ann N Y Acad Sci</source>.
<year>2019</year>;<volume>1457</volume>:<fpage>41</fpage>&#x2013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">31460675</pub-id></mixed-citation>
      </ref>
      <ref id="awac123-B59">
        <label>59</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsaousidou</surname>
<given-names>MK</given-names>
</string-name>, <string-name><surname>Ouahchi</surname><given-names>K</given-names></string-name>, <string-name><surname>Warner</surname><given-names>TT</given-names></string-name>, <etal>et
al</etal></person-group>
<article-title>Sequence alterations within CYP7B1 implicate defective cholesterol
homeostasis in motor-neuron degeneration</article-title>. <source>Am J Hum
Genet</source>.
<year>2008</year>;<volume>82</volume>:<fpage>510</fpage>&#x2013;<lpage>515</lpage>.<pub-id pub-id-type="pmid">18252231</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ER&#x2009;=</term>
          <def>
            <p>&#x2009;endoplasmic reticulum</p>
          </def>
        </def-item>
        <def-item>
          <term>HSP&#x2009;=</term>
          <def>
            <p>&#x2009;hereditary spastic paraplegia</p>
          </def>
        </def-item>
        <def-item>
          <term>MAM&#x2009;=</term>
          <def>
            <p>&#x2009;mitochondria-associated membranes</p>
          </def>
        </def-item>
        <def-item>
          <term>MERCs&#x2009;=</term>
          <def>
            <p>&#x2009;mitochondria-ER contact sites</p>
          </def>
        </def-item>
        <def-item>
          <term>siNT&#x2009;=</term>
          <def>
            <p>&#x2009;non-targeting small interfering RNA</p>
          </def>
        </def-item>
        <def-item>
          <term>siRNA&#x2009;=</term>
          <def>
            <p>&#x2009;small interfering RNA</p>
          </def>
        </def-item>
        <def-item>
          <term>SNP&#x2009;=</term>
          <def>
            <p>&#x2009;single nucleotide polymorphism</p>
          </def>
        </def-item>
        <def-item>
          <term>WES&#x2009;=</term>
          <def>
            <p>&#x2009;whole exome sequencing</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>
</pmc-articleset>